ESTRATEGIAS DE LA DETECCION TEMPRANA DE … · NHANES III ; USA . 66.3 % . 44 % . IBERPOC . España...

38
ESTRATEGIAS DE LA DETECCION TEMPRANA DE EPOC

Transcript of ESTRATEGIAS DE LA DETECCION TEMPRANA DE … · NHANES III ; USA . 66.3 % . 44 % . IBERPOC . España...

ESTRATEGIAS DE LA DETECCION TEMPRANA DE EPOC

Historia natural de la EPOC

Diagnoacutestico tardiacuteo dantildeo estructural

Signos oacute siacutentomas no reconocidos

Exposicioacuten al tabaco

Tiempo (antildeos)

Seve

rida

d

inicio

muerte

Umbral de

siacutentomas

Alteraciones funcionales

Cambios bioquiacutemicos y moleculares

Intervencioacuten tardiacutea

Exacerbaciones

Comorbilidades

Falla respiratoria

Muerte

Diagnoacutestico

temprano

Intervencioacuten

Temprano

Modificado de Petty Chest 2002121116S-20S

Soriano J et al Lancet 2009374721ndash32

Subdiagnoacutestico (89)

Subdiagnoacutestico

Estudio Paiacutes o Regioacuten No diagnosticados

No diagnosticados con FEV1 lt 50

NHANES III USA 663 44 IBERPOC Espantildea 783 HSE UK 812 48 PLATINO Latinoameacuterica 887 Bednarek Polonia 814 PREPOCOL Colombia 874 Bergen Noruega 66 0 33

IBERPOC 1997

EPISCAN 2007

Infradiagnoacutestico 78 73 Igual

Infratratamiento 81 54 Mejor

Infratratamiento en EPOC grave

50 10 Mejor

iquestEspirometriacutea previa 17 59 Mejor

Cambios en el infradiagnoacutestico e infratratamiento de la EPOC en Espantildea

1997-2007

Diferencias en el financiamiento del NIH para enfermedades especiacuteficas en USA

-100

-50

0

50

100

150

200

250

300

EPOC Neumoniacutea

Ca Pulmoacuten Asma

Cirrosis Cardiopatiacutea isqueacutemica

Diabetes Demencia

Ca Mama

SIDA 1287

Mill

ones

($)

Sobr

efin

anci

amie

nto

Subf

inan

ciam

ient

o

Gross CP et al NEJM 1999

Espirometriacutea herramienta clave

Tres fases

1 Inspiracioacuten maacutexima(maacutexima

capacidad)

2 ldquoSoplarrdquo con el maacuteximo esfuerzo

3 Y continuar exhalando hasta que no haya aire en los pulmones espiracioacuten de 6 segundos como miacutenimo

3 esfuerzos no maacutes de 8

Espiroacutemetro - Tensioacutemetro

EPOC ndash Hipertensioacuten arterial

Es posible hacer Diagnoacutestico Temprana

en la EPOC (Antes que los

siacutentomas)

COPD - PS

COPD ndash Population Screener

IPAG International Primary Care Airways Guidelines

Plan de 3 pasos

Eur Respir J 2012 Jun39(6)1458-1467 Epub 2012 Jan 20

The European Respiratory Society spirometry tent a unique form of screening for airway obstruction

Maio S Sherrill DL Macnee W Lange P Costabel U Dahleacuten SE Sybrecht GW Burghuber OC Stevenson R Toslashnnesen P Haeussinger K Hedlin GBauer TT Riedler J Nicod L Carlsen KH Viegi G on behalf of the European Respiratory SocietyEuropean Lung Foundation Spirometry Tent working group

Abstract

In order to raise public awareness of the importance of early detection of airway obstruction and to enable many people who had not been tested previously to have their lung function measured the European Lung Foundation and the European Respiratory Society (ERS) organised a spirometry testing tent during the annual ERS Congresses in 2004-2009 Spirometry was performed during the ERS Congresses in volunteers all participants answered a simple brief questionnaire on their descriptive characteristics smoking and asthma Portable spirometers were freely provided by the manufacturer Nurses and doctors from pulmonary departments of local hospitalsuniversities gave their service for free Lower limit of normal (LLN) and Global Initiative for Chronic Obstructive Lung Disease (GOLD) criteria for diagnosing and grading airway obstruction were used Of 12448 participants in six congress cities 10395 (835) performed acceptable spirometry (mean age 510plusmn184 yrs 255 smokers 55 asthmatic) Airway obstruction was present in 124 of investigated subjects according to LLN criteria and 203 according to GOLD criteria Through multinomial logistic regression analysis age smoking habits and asthma were significant risk factors for airway obstruction Relative risk ratio and 95 confidence interval for LLN stage I for example was 29 (20-41) for the youngest age (le19 yrs) 19 (12-30) for the oldest age (ge80 yrs) 24 (20-29) for current smokers and 28 (22-36) for reported asthma diagnosis In addition to being a useful advocacy tool the spirometry tent represents an unusual occasion for early detection of airway obstruction in large numbers of city residents with an important public health perspective

Eur Respir J 2012 Jun39(6)1458-1467 Epub 2012 Jan 20

The European Respiratory Society spirometry tent a unique form of screening for airway obstruction

Maio S Sherrill DL Macnee W Lange P Costabel U Dahleacuten SE Sybrecht GW Burghuber OC Stevenson R Toslashnnesen P Haeussinger K Hedlin GBauer TT Riedler J Nicod L Carlsen KH Viegi G on behalf of the European Respiratory SocietyEuropean Lung Foundation Spirometry Tent working group

Abstract

In order to raise public awareness of the importance of early detection of airway obstruction and to enable many people who had not been tested previously to have their lung function measured the European Lung Foundation and the European Respiratory Society (ERS) organised a spirometry testing tent during the annual ERS Congresses in 2004-2009 Spirometry was performed during the ERS Congresses in volunteers all participants answered a simple brief questionnaire on their descriptive characteristics smoking and asthma Portable spirometers were freely provided by the manufacturer Nurses and doctors from pulmonary departments of local hospitalsuniversities gave their service for free Lower limit of normal (LLN) and Global Initiative for Chronic Obstructive Lung Disease (GOLD) criteria for diagnosing and grading airway obstruction were used Of 12448 participants in six congress cities 10395 (835) performed acceptable spirometry (mean age 510plusmn184 yrs 255 smokers 55 asthmatic) Airway obstruction was present in 124 of investigated subjects according to LLN criteria and 203 according to GOLD criteria Through multinomial logistic regression analysis age smoking habits and asthma were significant risk factors for airway obstruction Relative risk ratio and 95 confidence interval for LLN stage I for example was 29 (20-41) for the youngest age (le19 yrs) 19 (12-30) for the oldest age (ge80 yrs) 24 (20-29) for current smokers and 28 (22-36) for reported asthma diagnosis In addition to being a useful advocacy tool the spirometry tent represents an unusual occasion for early detection of airway obstruction in large numbers of city residents with an important public health perspective

Seccioacuten de Inmunologiacutea y Enfermedades Obstructivas

World COPD Day Activities Are they useful to detect lack of medical care and undertreatment in COPD patients

37 CIUDADES 8 CIUDADES

1265 SUJETOS

335

EPOC

World COPD Day Activities Are they useful to detect lack of

medical care and undertreatment in COPD patients Immunology and Obstructive Lung Diseases Scientific Section from Argentine Respiratory Medicine Association

FarmaEPOC

100 farmacias de la provincia de Barcelona realizaraacuten escalonadamente espirometriacuteas ambulatorias a personas con factores de riesgo hasta alcanzar una muestra de 3600 usuarios Las espirometriacuteas seraacuten evaluadas con una aplicacioacuten telemaacutetica que permite no soacutelo garantizar la calidad de las espirometriacuteas realizadas sino mantener una comunicacioacuten on-line entre la farmacia y los laboratorios de funcioacuten pulmonar del Hospital Cliacutenic y el Hospital de Sant Pau FarmaEPOC 2 tiene como objetivo confirmar los datos del estudio piloto FarmaEPOC 1 que concluye la viabilidad de la prueba de la espirometriacutea en la oficina de farmacia De este modo FarmaEPOC 2 da un paso maacutes y surge de la necesidad de conocer tanto las caracteriacutesticas epidemioloacutegicas de los usuarios con alteracioacuten del flujo aeacutereo cribados en farmacias Abandono del tabaco principal estrategia de intervencioacuten precoz

Dejar de fumar agrega antildeos de vida

Aba

ndon

o a

los

45-5

4 antilde

os

Fumadores No fumadores Abandono a los 45-54 antildeos

n=34439 meacutedicos britaacutenicos

Antildeos

de sobrevida

desde edad promedio de 50 antildeos

Abandono en promedio a los 50 antildeos

bull Disminuye la mortalidad (A) bull Disminuye declinacioacuten funcional bull La educacioacuten es central (A)

Doll et al BMJ 2004 328 1519-1527

Seccioacuten de Inmunologiacutea y Enfermedades Obstructivas

2011

External validation to COPD deteccion questionnaire

Bergna M Garcia G Grabre P Alchapar R Larrateguy L Altieri H

Figueroa Casas JC Zabert G Nannini L Pascanky D Fucile S

CuestionariO de Deteccioacuten de EPOC CODE

EDAD gt58 ANtildeOS

gt20 PAQUETESANtildeOS TOS CRONICA

FLEMA CROacuteNICA DISNEA ESFUERZO SEXO MASCULINO

BMIlt22

CON SOLO 3 Sensibilidad de 95 y un VPN del 96

CONCLUSIONES bull Para mejorar los resultados globales de la Epoc

debemos detectarla mas tempranamente

bull Actividades en la comunidad cuestionarios espirometria abreviada son herramientas que colaboran con estos objetivos

bull Detectando y confirmando la Epoc por espirometria nuestros pacientes tendran mas oportunidades

Recomendaciones para el Diagnoacutestico y Tratamiento de la Enfermedad Pulmonar Obstructiva Croacutenica EPOC

Muchas Graciashellip

  • ESTRATEGIAS DE LA DETECCION TEMPRANA DE EPOC
  • Como mejorar nuestro manejo y enfoque sobre EPOC
  • Nuacutemero de diapositiva 3
  • Nuacutemero de diapositiva 4
  • Nuacutemero de diapositiva 5
  • Nuacutemero de diapositiva 6
  • Diferencias en el financiamiento del NIH para enfermedades especiacuteficas en USA
  • Espirometriacutea herramienta clave
  • Espiroacutemetro - Tensioacutemetro
  • Nuacutemero de diapositiva 10
  • Nuacutemero de diapositiva 11
  • COPD - PS
  • COPD ndash Population Screener
  • Nuacutemero de diapositiva 14
  • Nuacutemero de diapositiva 15
  • Nuacutemero de diapositiva 16
  • Nuacutemero de diapositiva 17
  • Nuacutemero de diapositiva 18
  • IPAG International Primary Care Airways Guidelines
  • Plan de 3 pasos
  • Nuacutemero de diapositiva 21
  • Nuacutemero de diapositiva 22
  • Nuacutemero de diapositiva 23
  • Nuacutemero de diapositiva 24
  • Nuacutemero de diapositiva 25
  • Eur Respir J 2012 Jun39(6)1458-1467 Epub 2012 Jan 20The European Respiratory Society spirometry tent a unique form of screening for airway obstruction
  • Eur Respir J 2012 Jun39(6)1458-1467 Epub 2012 Jan 20The European Respiratory Society spirometry tent a unique form of screening for airway obstruction
  • Nuacutemero de diapositiva 28
  • Nuacutemero de diapositiva 29
  • 13World COPD Day Activities Are they useful to detect lack of medical care and undertreatment in COPD patients13Immunology and Obstructive Lung Diseases Scientific Section from Argentine Respiratory Medicine Association
  • FarmaEPOC
  • Nuacutemero de diapositiva 32
  • Dejar de fumar agrega antildeos de vida
  • Nuacutemero de diapositiva 34
  • Nuacutemero de diapositiva 35
  • Nuacutemero de diapositiva 36
  • CONCLUSIONES
  • Nuacutemero de diapositiva 38

Historia natural de la EPOC

Diagnoacutestico tardiacuteo dantildeo estructural

Signos oacute siacutentomas no reconocidos

Exposicioacuten al tabaco

Tiempo (antildeos)

Seve

rida

d

inicio

muerte

Umbral de

siacutentomas

Alteraciones funcionales

Cambios bioquiacutemicos y moleculares

Intervencioacuten tardiacutea

Exacerbaciones

Comorbilidades

Falla respiratoria

Muerte

Diagnoacutestico

temprano

Intervencioacuten

Temprano

Modificado de Petty Chest 2002121116S-20S

Soriano J et al Lancet 2009374721ndash32

Subdiagnoacutestico (89)

Subdiagnoacutestico

Estudio Paiacutes o Regioacuten No diagnosticados

No diagnosticados con FEV1 lt 50

NHANES III USA 663 44 IBERPOC Espantildea 783 HSE UK 812 48 PLATINO Latinoameacuterica 887 Bednarek Polonia 814 PREPOCOL Colombia 874 Bergen Noruega 66 0 33

IBERPOC 1997

EPISCAN 2007

Infradiagnoacutestico 78 73 Igual

Infratratamiento 81 54 Mejor

Infratratamiento en EPOC grave

50 10 Mejor

iquestEspirometriacutea previa 17 59 Mejor

Cambios en el infradiagnoacutestico e infratratamiento de la EPOC en Espantildea

1997-2007

Diferencias en el financiamiento del NIH para enfermedades especiacuteficas en USA

-100

-50

0

50

100

150

200

250

300

EPOC Neumoniacutea

Ca Pulmoacuten Asma

Cirrosis Cardiopatiacutea isqueacutemica

Diabetes Demencia

Ca Mama

SIDA 1287

Mill

ones

($)

Sobr

efin

anci

amie

nto

Subf

inan

ciam

ient

o

Gross CP et al NEJM 1999

Espirometriacutea herramienta clave

Tres fases

1 Inspiracioacuten maacutexima(maacutexima

capacidad)

2 ldquoSoplarrdquo con el maacuteximo esfuerzo

3 Y continuar exhalando hasta que no haya aire en los pulmones espiracioacuten de 6 segundos como miacutenimo

3 esfuerzos no maacutes de 8

Espiroacutemetro - Tensioacutemetro

EPOC ndash Hipertensioacuten arterial

Es posible hacer Diagnoacutestico Temprana

en la EPOC (Antes que los

siacutentomas)

COPD - PS

COPD ndash Population Screener

IPAG International Primary Care Airways Guidelines

Plan de 3 pasos

Eur Respir J 2012 Jun39(6)1458-1467 Epub 2012 Jan 20

The European Respiratory Society spirometry tent a unique form of screening for airway obstruction

Maio S Sherrill DL Macnee W Lange P Costabel U Dahleacuten SE Sybrecht GW Burghuber OC Stevenson R Toslashnnesen P Haeussinger K Hedlin GBauer TT Riedler J Nicod L Carlsen KH Viegi G on behalf of the European Respiratory SocietyEuropean Lung Foundation Spirometry Tent working group

Abstract

In order to raise public awareness of the importance of early detection of airway obstruction and to enable many people who had not been tested previously to have their lung function measured the European Lung Foundation and the European Respiratory Society (ERS) organised a spirometry testing tent during the annual ERS Congresses in 2004-2009 Spirometry was performed during the ERS Congresses in volunteers all participants answered a simple brief questionnaire on their descriptive characteristics smoking and asthma Portable spirometers were freely provided by the manufacturer Nurses and doctors from pulmonary departments of local hospitalsuniversities gave their service for free Lower limit of normal (LLN) and Global Initiative for Chronic Obstructive Lung Disease (GOLD) criteria for diagnosing and grading airway obstruction were used Of 12448 participants in six congress cities 10395 (835) performed acceptable spirometry (mean age 510plusmn184 yrs 255 smokers 55 asthmatic) Airway obstruction was present in 124 of investigated subjects according to LLN criteria and 203 according to GOLD criteria Through multinomial logistic regression analysis age smoking habits and asthma were significant risk factors for airway obstruction Relative risk ratio and 95 confidence interval for LLN stage I for example was 29 (20-41) for the youngest age (le19 yrs) 19 (12-30) for the oldest age (ge80 yrs) 24 (20-29) for current smokers and 28 (22-36) for reported asthma diagnosis In addition to being a useful advocacy tool the spirometry tent represents an unusual occasion for early detection of airway obstruction in large numbers of city residents with an important public health perspective

Eur Respir J 2012 Jun39(6)1458-1467 Epub 2012 Jan 20

The European Respiratory Society spirometry tent a unique form of screening for airway obstruction

Maio S Sherrill DL Macnee W Lange P Costabel U Dahleacuten SE Sybrecht GW Burghuber OC Stevenson R Toslashnnesen P Haeussinger K Hedlin GBauer TT Riedler J Nicod L Carlsen KH Viegi G on behalf of the European Respiratory SocietyEuropean Lung Foundation Spirometry Tent working group

Abstract

In order to raise public awareness of the importance of early detection of airway obstruction and to enable many people who had not been tested previously to have their lung function measured the European Lung Foundation and the European Respiratory Society (ERS) organised a spirometry testing tent during the annual ERS Congresses in 2004-2009 Spirometry was performed during the ERS Congresses in volunteers all participants answered a simple brief questionnaire on their descriptive characteristics smoking and asthma Portable spirometers were freely provided by the manufacturer Nurses and doctors from pulmonary departments of local hospitalsuniversities gave their service for free Lower limit of normal (LLN) and Global Initiative for Chronic Obstructive Lung Disease (GOLD) criteria for diagnosing and grading airway obstruction were used Of 12448 participants in six congress cities 10395 (835) performed acceptable spirometry (mean age 510plusmn184 yrs 255 smokers 55 asthmatic) Airway obstruction was present in 124 of investigated subjects according to LLN criteria and 203 according to GOLD criteria Through multinomial logistic regression analysis age smoking habits and asthma were significant risk factors for airway obstruction Relative risk ratio and 95 confidence interval for LLN stage I for example was 29 (20-41) for the youngest age (le19 yrs) 19 (12-30) for the oldest age (ge80 yrs) 24 (20-29) for current smokers and 28 (22-36) for reported asthma diagnosis In addition to being a useful advocacy tool the spirometry tent represents an unusual occasion for early detection of airway obstruction in large numbers of city residents with an important public health perspective

Seccioacuten de Inmunologiacutea y Enfermedades Obstructivas

World COPD Day Activities Are they useful to detect lack of medical care and undertreatment in COPD patients

37 CIUDADES 8 CIUDADES

1265 SUJETOS

335

EPOC

World COPD Day Activities Are they useful to detect lack of

medical care and undertreatment in COPD patients Immunology and Obstructive Lung Diseases Scientific Section from Argentine Respiratory Medicine Association

FarmaEPOC

100 farmacias de la provincia de Barcelona realizaraacuten escalonadamente espirometriacuteas ambulatorias a personas con factores de riesgo hasta alcanzar una muestra de 3600 usuarios Las espirometriacuteas seraacuten evaluadas con una aplicacioacuten telemaacutetica que permite no soacutelo garantizar la calidad de las espirometriacuteas realizadas sino mantener una comunicacioacuten on-line entre la farmacia y los laboratorios de funcioacuten pulmonar del Hospital Cliacutenic y el Hospital de Sant Pau FarmaEPOC 2 tiene como objetivo confirmar los datos del estudio piloto FarmaEPOC 1 que concluye la viabilidad de la prueba de la espirometriacutea en la oficina de farmacia De este modo FarmaEPOC 2 da un paso maacutes y surge de la necesidad de conocer tanto las caracteriacutesticas epidemioloacutegicas de los usuarios con alteracioacuten del flujo aeacutereo cribados en farmacias Abandono del tabaco principal estrategia de intervencioacuten precoz

Dejar de fumar agrega antildeos de vida

Aba

ndon

o a

los

45-5

4 antilde

os

Fumadores No fumadores Abandono a los 45-54 antildeos

n=34439 meacutedicos britaacutenicos

Antildeos

de sobrevida

desde edad promedio de 50 antildeos

Abandono en promedio a los 50 antildeos

bull Disminuye la mortalidad (A) bull Disminuye declinacioacuten funcional bull La educacioacuten es central (A)

Doll et al BMJ 2004 328 1519-1527

Seccioacuten de Inmunologiacutea y Enfermedades Obstructivas

2011

External validation to COPD deteccion questionnaire

Bergna M Garcia G Grabre P Alchapar R Larrateguy L Altieri H

Figueroa Casas JC Zabert G Nannini L Pascanky D Fucile S

CuestionariO de Deteccioacuten de EPOC CODE

EDAD gt58 ANtildeOS

gt20 PAQUETESANtildeOS TOS CRONICA

FLEMA CROacuteNICA DISNEA ESFUERZO SEXO MASCULINO

BMIlt22

CON SOLO 3 Sensibilidad de 95 y un VPN del 96

CONCLUSIONES bull Para mejorar los resultados globales de la Epoc

debemos detectarla mas tempranamente

bull Actividades en la comunidad cuestionarios espirometria abreviada son herramientas que colaboran con estos objetivos

bull Detectando y confirmando la Epoc por espirometria nuestros pacientes tendran mas oportunidades

Recomendaciones para el Diagnoacutestico y Tratamiento de la Enfermedad Pulmonar Obstructiva Croacutenica EPOC

Muchas Graciashellip

  • ESTRATEGIAS DE LA DETECCION TEMPRANA DE EPOC
  • Como mejorar nuestro manejo y enfoque sobre EPOC
  • Nuacutemero de diapositiva 3
  • Nuacutemero de diapositiva 4
  • Nuacutemero de diapositiva 5
  • Nuacutemero de diapositiva 6
  • Diferencias en el financiamiento del NIH para enfermedades especiacuteficas en USA
  • Espirometriacutea herramienta clave
  • Espiroacutemetro - Tensioacutemetro
  • Nuacutemero de diapositiva 10
  • Nuacutemero de diapositiva 11
  • COPD - PS
  • COPD ndash Population Screener
  • Nuacutemero de diapositiva 14
  • Nuacutemero de diapositiva 15
  • Nuacutemero de diapositiva 16
  • Nuacutemero de diapositiva 17
  • Nuacutemero de diapositiva 18
  • IPAG International Primary Care Airways Guidelines
  • Plan de 3 pasos
  • Nuacutemero de diapositiva 21
  • Nuacutemero de diapositiva 22
  • Nuacutemero de diapositiva 23
  • Nuacutemero de diapositiva 24
  • Nuacutemero de diapositiva 25
  • Eur Respir J 2012 Jun39(6)1458-1467 Epub 2012 Jan 20The European Respiratory Society spirometry tent a unique form of screening for airway obstruction
  • Eur Respir J 2012 Jun39(6)1458-1467 Epub 2012 Jan 20The European Respiratory Society spirometry tent a unique form of screening for airway obstruction
  • Nuacutemero de diapositiva 28
  • Nuacutemero de diapositiva 29
  • 13World COPD Day Activities Are they useful to detect lack of medical care and undertreatment in COPD patients13Immunology and Obstructive Lung Diseases Scientific Section from Argentine Respiratory Medicine Association
  • FarmaEPOC
  • Nuacutemero de diapositiva 32
  • Dejar de fumar agrega antildeos de vida
  • Nuacutemero de diapositiva 34
  • Nuacutemero de diapositiva 35
  • Nuacutemero de diapositiva 36
  • CONCLUSIONES
  • Nuacutemero de diapositiva 38

Soriano J et al Lancet 2009374721ndash32

Subdiagnoacutestico (89)

Subdiagnoacutestico

Estudio Paiacutes o Regioacuten No diagnosticados

No diagnosticados con FEV1 lt 50

NHANES III USA 663 44 IBERPOC Espantildea 783 HSE UK 812 48 PLATINO Latinoameacuterica 887 Bednarek Polonia 814 PREPOCOL Colombia 874 Bergen Noruega 66 0 33

IBERPOC 1997

EPISCAN 2007

Infradiagnoacutestico 78 73 Igual

Infratratamiento 81 54 Mejor

Infratratamiento en EPOC grave

50 10 Mejor

iquestEspirometriacutea previa 17 59 Mejor

Cambios en el infradiagnoacutestico e infratratamiento de la EPOC en Espantildea

1997-2007

Diferencias en el financiamiento del NIH para enfermedades especiacuteficas en USA

-100

-50

0

50

100

150

200

250

300

EPOC Neumoniacutea

Ca Pulmoacuten Asma

Cirrosis Cardiopatiacutea isqueacutemica

Diabetes Demencia

Ca Mama

SIDA 1287

Mill

ones

($)

Sobr

efin

anci

amie

nto

Subf

inan

ciam

ient

o

Gross CP et al NEJM 1999

Espirometriacutea herramienta clave

Tres fases

1 Inspiracioacuten maacutexima(maacutexima

capacidad)

2 ldquoSoplarrdquo con el maacuteximo esfuerzo

3 Y continuar exhalando hasta que no haya aire en los pulmones espiracioacuten de 6 segundos como miacutenimo

3 esfuerzos no maacutes de 8

Espiroacutemetro - Tensioacutemetro

EPOC ndash Hipertensioacuten arterial

Es posible hacer Diagnoacutestico Temprana

en la EPOC (Antes que los

siacutentomas)

COPD - PS

COPD ndash Population Screener

IPAG International Primary Care Airways Guidelines

Plan de 3 pasos

Eur Respir J 2012 Jun39(6)1458-1467 Epub 2012 Jan 20

The European Respiratory Society spirometry tent a unique form of screening for airway obstruction

Maio S Sherrill DL Macnee W Lange P Costabel U Dahleacuten SE Sybrecht GW Burghuber OC Stevenson R Toslashnnesen P Haeussinger K Hedlin GBauer TT Riedler J Nicod L Carlsen KH Viegi G on behalf of the European Respiratory SocietyEuropean Lung Foundation Spirometry Tent working group

Abstract

In order to raise public awareness of the importance of early detection of airway obstruction and to enable many people who had not been tested previously to have their lung function measured the European Lung Foundation and the European Respiratory Society (ERS) organised a spirometry testing tent during the annual ERS Congresses in 2004-2009 Spirometry was performed during the ERS Congresses in volunteers all participants answered a simple brief questionnaire on their descriptive characteristics smoking and asthma Portable spirometers were freely provided by the manufacturer Nurses and doctors from pulmonary departments of local hospitalsuniversities gave their service for free Lower limit of normal (LLN) and Global Initiative for Chronic Obstructive Lung Disease (GOLD) criteria for diagnosing and grading airway obstruction were used Of 12448 participants in six congress cities 10395 (835) performed acceptable spirometry (mean age 510plusmn184 yrs 255 smokers 55 asthmatic) Airway obstruction was present in 124 of investigated subjects according to LLN criteria and 203 according to GOLD criteria Through multinomial logistic regression analysis age smoking habits and asthma were significant risk factors for airway obstruction Relative risk ratio and 95 confidence interval for LLN stage I for example was 29 (20-41) for the youngest age (le19 yrs) 19 (12-30) for the oldest age (ge80 yrs) 24 (20-29) for current smokers and 28 (22-36) for reported asthma diagnosis In addition to being a useful advocacy tool the spirometry tent represents an unusual occasion for early detection of airway obstruction in large numbers of city residents with an important public health perspective

Eur Respir J 2012 Jun39(6)1458-1467 Epub 2012 Jan 20

The European Respiratory Society spirometry tent a unique form of screening for airway obstruction

Maio S Sherrill DL Macnee W Lange P Costabel U Dahleacuten SE Sybrecht GW Burghuber OC Stevenson R Toslashnnesen P Haeussinger K Hedlin GBauer TT Riedler J Nicod L Carlsen KH Viegi G on behalf of the European Respiratory SocietyEuropean Lung Foundation Spirometry Tent working group

Abstract

In order to raise public awareness of the importance of early detection of airway obstruction and to enable many people who had not been tested previously to have their lung function measured the European Lung Foundation and the European Respiratory Society (ERS) organised a spirometry testing tent during the annual ERS Congresses in 2004-2009 Spirometry was performed during the ERS Congresses in volunteers all participants answered a simple brief questionnaire on their descriptive characteristics smoking and asthma Portable spirometers were freely provided by the manufacturer Nurses and doctors from pulmonary departments of local hospitalsuniversities gave their service for free Lower limit of normal (LLN) and Global Initiative for Chronic Obstructive Lung Disease (GOLD) criteria for diagnosing and grading airway obstruction were used Of 12448 participants in six congress cities 10395 (835) performed acceptable spirometry (mean age 510plusmn184 yrs 255 smokers 55 asthmatic) Airway obstruction was present in 124 of investigated subjects according to LLN criteria and 203 according to GOLD criteria Through multinomial logistic regression analysis age smoking habits and asthma were significant risk factors for airway obstruction Relative risk ratio and 95 confidence interval for LLN stage I for example was 29 (20-41) for the youngest age (le19 yrs) 19 (12-30) for the oldest age (ge80 yrs) 24 (20-29) for current smokers and 28 (22-36) for reported asthma diagnosis In addition to being a useful advocacy tool the spirometry tent represents an unusual occasion for early detection of airway obstruction in large numbers of city residents with an important public health perspective

Seccioacuten de Inmunologiacutea y Enfermedades Obstructivas

World COPD Day Activities Are they useful to detect lack of medical care and undertreatment in COPD patients

37 CIUDADES 8 CIUDADES

1265 SUJETOS

335

EPOC

World COPD Day Activities Are they useful to detect lack of

medical care and undertreatment in COPD patients Immunology and Obstructive Lung Diseases Scientific Section from Argentine Respiratory Medicine Association

FarmaEPOC

100 farmacias de la provincia de Barcelona realizaraacuten escalonadamente espirometriacuteas ambulatorias a personas con factores de riesgo hasta alcanzar una muestra de 3600 usuarios Las espirometriacuteas seraacuten evaluadas con una aplicacioacuten telemaacutetica que permite no soacutelo garantizar la calidad de las espirometriacuteas realizadas sino mantener una comunicacioacuten on-line entre la farmacia y los laboratorios de funcioacuten pulmonar del Hospital Cliacutenic y el Hospital de Sant Pau FarmaEPOC 2 tiene como objetivo confirmar los datos del estudio piloto FarmaEPOC 1 que concluye la viabilidad de la prueba de la espirometriacutea en la oficina de farmacia De este modo FarmaEPOC 2 da un paso maacutes y surge de la necesidad de conocer tanto las caracteriacutesticas epidemioloacutegicas de los usuarios con alteracioacuten del flujo aeacutereo cribados en farmacias Abandono del tabaco principal estrategia de intervencioacuten precoz

Dejar de fumar agrega antildeos de vida

Aba

ndon

o a

los

45-5

4 antilde

os

Fumadores No fumadores Abandono a los 45-54 antildeos

n=34439 meacutedicos britaacutenicos

Antildeos

de sobrevida

desde edad promedio de 50 antildeos

Abandono en promedio a los 50 antildeos

bull Disminuye la mortalidad (A) bull Disminuye declinacioacuten funcional bull La educacioacuten es central (A)

Doll et al BMJ 2004 328 1519-1527

Seccioacuten de Inmunologiacutea y Enfermedades Obstructivas

2011

External validation to COPD deteccion questionnaire

Bergna M Garcia G Grabre P Alchapar R Larrateguy L Altieri H

Figueroa Casas JC Zabert G Nannini L Pascanky D Fucile S

CuestionariO de Deteccioacuten de EPOC CODE

EDAD gt58 ANtildeOS

gt20 PAQUETESANtildeOS TOS CRONICA

FLEMA CROacuteNICA DISNEA ESFUERZO SEXO MASCULINO

BMIlt22

CON SOLO 3 Sensibilidad de 95 y un VPN del 96

CONCLUSIONES bull Para mejorar los resultados globales de la Epoc

debemos detectarla mas tempranamente

bull Actividades en la comunidad cuestionarios espirometria abreviada son herramientas que colaboran con estos objetivos

bull Detectando y confirmando la Epoc por espirometria nuestros pacientes tendran mas oportunidades

Recomendaciones para el Diagnoacutestico y Tratamiento de la Enfermedad Pulmonar Obstructiva Croacutenica EPOC

Muchas Graciashellip

  • ESTRATEGIAS DE LA DETECCION TEMPRANA DE EPOC
  • Como mejorar nuestro manejo y enfoque sobre EPOC
  • Nuacutemero de diapositiva 3
  • Nuacutemero de diapositiva 4
  • Nuacutemero de diapositiva 5
  • Nuacutemero de diapositiva 6
  • Diferencias en el financiamiento del NIH para enfermedades especiacuteficas en USA
  • Espirometriacutea herramienta clave
  • Espiroacutemetro - Tensioacutemetro
  • Nuacutemero de diapositiva 10
  • Nuacutemero de diapositiva 11
  • COPD - PS
  • COPD ndash Population Screener
  • Nuacutemero de diapositiva 14
  • Nuacutemero de diapositiva 15
  • Nuacutemero de diapositiva 16
  • Nuacutemero de diapositiva 17
  • Nuacutemero de diapositiva 18
  • IPAG International Primary Care Airways Guidelines
  • Plan de 3 pasos
  • Nuacutemero de diapositiva 21
  • Nuacutemero de diapositiva 22
  • Nuacutemero de diapositiva 23
  • Nuacutemero de diapositiva 24
  • Nuacutemero de diapositiva 25
  • Eur Respir J 2012 Jun39(6)1458-1467 Epub 2012 Jan 20The European Respiratory Society spirometry tent a unique form of screening for airway obstruction
  • Eur Respir J 2012 Jun39(6)1458-1467 Epub 2012 Jan 20The European Respiratory Society spirometry tent a unique form of screening for airway obstruction
  • Nuacutemero de diapositiva 28
  • Nuacutemero de diapositiva 29
  • 13World COPD Day Activities Are they useful to detect lack of medical care and undertreatment in COPD patients13Immunology and Obstructive Lung Diseases Scientific Section from Argentine Respiratory Medicine Association
  • FarmaEPOC
  • Nuacutemero de diapositiva 32
  • Dejar de fumar agrega antildeos de vida
  • Nuacutemero de diapositiva 34
  • Nuacutemero de diapositiva 35
  • Nuacutemero de diapositiva 36
  • CONCLUSIONES
  • Nuacutemero de diapositiva 38

Subdiagnoacutestico

Estudio Paiacutes o Regioacuten No diagnosticados

No diagnosticados con FEV1 lt 50

NHANES III USA 663 44 IBERPOC Espantildea 783 HSE UK 812 48 PLATINO Latinoameacuterica 887 Bednarek Polonia 814 PREPOCOL Colombia 874 Bergen Noruega 66 0 33

IBERPOC 1997

EPISCAN 2007

Infradiagnoacutestico 78 73 Igual

Infratratamiento 81 54 Mejor

Infratratamiento en EPOC grave

50 10 Mejor

iquestEspirometriacutea previa 17 59 Mejor

Cambios en el infradiagnoacutestico e infratratamiento de la EPOC en Espantildea

1997-2007

Diferencias en el financiamiento del NIH para enfermedades especiacuteficas en USA

-100

-50

0

50

100

150

200

250

300

EPOC Neumoniacutea

Ca Pulmoacuten Asma

Cirrosis Cardiopatiacutea isqueacutemica

Diabetes Demencia

Ca Mama

SIDA 1287

Mill

ones

($)

Sobr

efin

anci

amie

nto

Subf

inan

ciam

ient

o

Gross CP et al NEJM 1999

Espirometriacutea herramienta clave

Tres fases

1 Inspiracioacuten maacutexima(maacutexima

capacidad)

2 ldquoSoplarrdquo con el maacuteximo esfuerzo

3 Y continuar exhalando hasta que no haya aire en los pulmones espiracioacuten de 6 segundos como miacutenimo

3 esfuerzos no maacutes de 8

Espiroacutemetro - Tensioacutemetro

EPOC ndash Hipertensioacuten arterial

Es posible hacer Diagnoacutestico Temprana

en la EPOC (Antes que los

siacutentomas)

COPD - PS

COPD ndash Population Screener

IPAG International Primary Care Airways Guidelines

Plan de 3 pasos

Eur Respir J 2012 Jun39(6)1458-1467 Epub 2012 Jan 20

The European Respiratory Society spirometry tent a unique form of screening for airway obstruction

Maio S Sherrill DL Macnee W Lange P Costabel U Dahleacuten SE Sybrecht GW Burghuber OC Stevenson R Toslashnnesen P Haeussinger K Hedlin GBauer TT Riedler J Nicod L Carlsen KH Viegi G on behalf of the European Respiratory SocietyEuropean Lung Foundation Spirometry Tent working group

Abstract

In order to raise public awareness of the importance of early detection of airway obstruction and to enable many people who had not been tested previously to have their lung function measured the European Lung Foundation and the European Respiratory Society (ERS) organised a spirometry testing tent during the annual ERS Congresses in 2004-2009 Spirometry was performed during the ERS Congresses in volunteers all participants answered a simple brief questionnaire on their descriptive characteristics smoking and asthma Portable spirometers were freely provided by the manufacturer Nurses and doctors from pulmonary departments of local hospitalsuniversities gave their service for free Lower limit of normal (LLN) and Global Initiative for Chronic Obstructive Lung Disease (GOLD) criteria for diagnosing and grading airway obstruction were used Of 12448 participants in six congress cities 10395 (835) performed acceptable spirometry (mean age 510plusmn184 yrs 255 smokers 55 asthmatic) Airway obstruction was present in 124 of investigated subjects according to LLN criteria and 203 according to GOLD criteria Through multinomial logistic regression analysis age smoking habits and asthma were significant risk factors for airway obstruction Relative risk ratio and 95 confidence interval for LLN stage I for example was 29 (20-41) for the youngest age (le19 yrs) 19 (12-30) for the oldest age (ge80 yrs) 24 (20-29) for current smokers and 28 (22-36) for reported asthma diagnosis In addition to being a useful advocacy tool the spirometry tent represents an unusual occasion for early detection of airway obstruction in large numbers of city residents with an important public health perspective

Eur Respir J 2012 Jun39(6)1458-1467 Epub 2012 Jan 20

The European Respiratory Society spirometry tent a unique form of screening for airway obstruction

Maio S Sherrill DL Macnee W Lange P Costabel U Dahleacuten SE Sybrecht GW Burghuber OC Stevenson R Toslashnnesen P Haeussinger K Hedlin GBauer TT Riedler J Nicod L Carlsen KH Viegi G on behalf of the European Respiratory SocietyEuropean Lung Foundation Spirometry Tent working group

Abstract

In order to raise public awareness of the importance of early detection of airway obstruction and to enable many people who had not been tested previously to have their lung function measured the European Lung Foundation and the European Respiratory Society (ERS) organised a spirometry testing tent during the annual ERS Congresses in 2004-2009 Spirometry was performed during the ERS Congresses in volunteers all participants answered a simple brief questionnaire on their descriptive characteristics smoking and asthma Portable spirometers were freely provided by the manufacturer Nurses and doctors from pulmonary departments of local hospitalsuniversities gave their service for free Lower limit of normal (LLN) and Global Initiative for Chronic Obstructive Lung Disease (GOLD) criteria for diagnosing and grading airway obstruction were used Of 12448 participants in six congress cities 10395 (835) performed acceptable spirometry (mean age 510plusmn184 yrs 255 smokers 55 asthmatic) Airway obstruction was present in 124 of investigated subjects according to LLN criteria and 203 according to GOLD criteria Through multinomial logistic regression analysis age smoking habits and asthma were significant risk factors for airway obstruction Relative risk ratio and 95 confidence interval for LLN stage I for example was 29 (20-41) for the youngest age (le19 yrs) 19 (12-30) for the oldest age (ge80 yrs) 24 (20-29) for current smokers and 28 (22-36) for reported asthma diagnosis In addition to being a useful advocacy tool the spirometry tent represents an unusual occasion for early detection of airway obstruction in large numbers of city residents with an important public health perspective

Seccioacuten de Inmunologiacutea y Enfermedades Obstructivas

World COPD Day Activities Are they useful to detect lack of medical care and undertreatment in COPD patients

37 CIUDADES 8 CIUDADES

1265 SUJETOS

335

EPOC

World COPD Day Activities Are they useful to detect lack of

medical care and undertreatment in COPD patients Immunology and Obstructive Lung Diseases Scientific Section from Argentine Respiratory Medicine Association

FarmaEPOC

100 farmacias de la provincia de Barcelona realizaraacuten escalonadamente espirometriacuteas ambulatorias a personas con factores de riesgo hasta alcanzar una muestra de 3600 usuarios Las espirometriacuteas seraacuten evaluadas con una aplicacioacuten telemaacutetica que permite no soacutelo garantizar la calidad de las espirometriacuteas realizadas sino mantener una comunicacioacuten on-line entre la farmacia y los laboratorios de funcioacuten pulmonar del Hospital Cliacutenic y el Hospital de Sant Pau FarmaEPOC 2 tiene como objetivo confirmar los datos del estudio piloto FarmaEPOC 1 que concluye la viabilidad de la prueba de la espirometriacutea en la oficina de farmacia De este modo FarmaEPOC 2 da un paso maacutes y surge de la necesidad de conocer tanto las caracteriacutesticas epidemioloacutegicas de los usuarios con alteracioacuten del flujo aeacutereo cribados en farmacias Abandono del tabaco principal estrategia de intervencioacuten precoz

Dejar de fumar agrega antildeos de vida

Aba

ndon

o a

los

45-5

4 antilde

os

Fumadores No fumadores Abandono a los 45-54 antildeos

n=34439 meacutedicos britaacutenicos

Antildeos

de sobrevida

desde edad promedio de 50 antildeos

Abandono en promedio a los 50 antildeos

bull Disminuye la mortalidad (A) bull Disminuye declinacioacuten funcional bull La educacioacuten es central (A)

Doll et al BMJ 2004 328 1519-1527

Seccioacuten de Inmunologiacutea y Enfermedades Obstructivas

2011

External validation to COPD deteccion questionnaire

Bergna M Garcia G Grabre P Alchapar R Larrateguy L Altieri H

Figueroa Casas JC Zabert G Nannini L Pascanky D Fucile S

CuestionariO de Deteccioacuten de EPOC CODE

EDAD gt58 ANtildeOS

gt20 PAQUETESANtildeOS TOS CRONICA

FLEMA CROacuteNICA DISNEA ESFUERZO SEXO MASCULINO

BMIlt22

CON SOLO 3 Sensibilidad de 95 y un VPN del 96

CONCLUSIONES bull Para mejorar los resultados globales de la Epoc

debemos detectarla mas tempranamente

bull Actividades en la comunidad cuestionarios espirometria abreviada son herramientas que colaboran con estos objetivos

bull Detectando y confirmando la Epoc por espirometria nuestros pacientes tendran mas oportunidades

Recomendaciones para el Diagnoacutestico y Tratamiento de la Enfermedad Pulmonar Obstructiva Croacutenica EPOC

Muchas Graciashellip

  • ESTRATEGIAS DE LA DETECCION TEMPRANA DE EPOC
  • Como mejorar nuestro manejo y enfoque sobre EPOC
  • Nuacutemero de diapositiva 3
  • Nuacutemero de diapositiva 4
  • Nuacutemero de diapositiva 5
  • Nuacutemero de diapositiva 6
  • Diferencias en el financiamiento del NIH para enfermedades especiacuteficas en USA
  • Espirometriacutea herramienta clave
  • Espiroacutemetro - Tensioacutemetro
  • Nuacutemero de diapositiva 10
  • Nuacutemero de diapositiva 11
  • COPD - PS
  • COPD ndash Population Screener
  • Nuacutemero de diapositiva 14
  • Nuacutemero de diapositiva 15
  • Nuacutemero de diapositiva 16
  • Nuacutemero de diapositiva 17
  • Nuacutemero de diapositiva 18
  • IPAG International Primary Care Airways Guidelines
  • Plan de 3 pasos
  • Nuacutemero de diapositiva 21
  • Nuacutemero de diapositiva 22
  • Nuacutemero de diapositiva 23
  • Nuacutemero de diapositiva 24
  • Nuacutemero de diapositiva 25
  • Eur Respir J 2012 Jun39(6)1458-1467 Epub 2012 Jan 20The European Respiratory Society spirometry tent a unique form of screening for airway obstruction
  • Eur Respir J 2012 Jun39(6)1458-1467 Epub 2012 Jan 20The European Respiratory Society spirometry tent a unique form of screening for airway obstruction
  • Nuacutemero de diapositiva 28
  • Nuacutemero de diapositiva 29
  • 13World COPD Day Activities Are they useful to detect lack of medical care and undertreatment in COPD patients13Immunology and Obstructive Lung Diseases Scientific Section from Argentine Respiratory Medicine Association
  • FarmaEPOC
  • Nuacutemero de diapositiva 32
  • Dejar de fumar agrega antildeos de vida
  • Nuacutemero de diapositiva 34
  • Nuacutemero de diapositiva 35
  • Nuacutemero de diapositiva 36
  • CONCLUSIONES
  • Nuacutemero de diapositiva 38

IBERPOC 1997

EPISCAN 2007

Infradiagnoacutestico 78 73 Igual

Infratratamiento 81 54 Mejor

Infratratamiento en EPOC grave

50 10 Mejor

iquestEspirometriacutea previa 17 59 Mejor

Cambios en el infradiagnoacutestico e infratratamiento de la EPOC en Espantildea

1997-2007

Diferencias en el financiamiento del NIH para enfermedades especiacuteficas en USA

-100

-50

0

50

100

150

200

250

300

EPOC Neumoniacutea

Ca Pulmoacuten Asma

Cirrosis Cardiopatiacutea isqueacutemica

Diabetes Demencia

Ca Mama

SIDA 1287

Mill

ones

($)

Sobr

efin

anci

amie

nto

Subf

inan

ciam

ient

o

Gross CP et al NEJM 1999

Espirometriacutea herramienta clave

Tres fases

1 Inspiracioacuten maacutexima(maacutexima

capacidad)

2 ldquoSoplarrdquo con el maacuteximo esfuerzo

3 Y continuar exhalando hasta que no haya aire en los pulmones espiracioacuten de 6 segundos como miacutenimo

3 esfuerzos no maacutes de 8

Espiroacutemetro - Tensioacutemetro

EPOC ndash Hipertensioacuten arterial

Es posible hacer Diagnoacutestico Temprana

en la EPOC (Antes que los

siacutentomas)

COPD - PS

COPD ndash Population Screener

IPAG International Primary Care Airways Guidelines

Plan de 3 pasos

Eur Respir J 2012 Jun39(6)1458-1467 Epub 2012 Jan 20

The European Respiratory Society spirometry tent a unique form of screening for airway obstruction

Maio S Sherrill DL Macnee W Lange P Costabel U Dahleacuten SE Sybrecht GW Burghuber OC Stevenson R Toslashnnesen P Haeussinger K Hedlin GBauer TT Riedler J Nicod L Carlsen KH Viegi G on behalf of the European Respiratory SocietyEuropean Lung Foundation Spirometry Tent working group

Abstract

In order to raise public awareness of the importance of early detection of airway obstruction and to enable many people who had not been tested previously to have their lung function measured the European Lung Foundation and the European Respiratory Society (ERS) organised a spirometry testing tent during the annual ERS Congresses in 2004-2009 Spirometry was performed during the ERS Congresses in volunteers all participants answered a simple brief questionnaire on their descriptive characteristics smoking and asthma Portable spirometers were freely provided by the manufacturer Nurses and doctors from pulmonary departments of local hospitalsuniversities gave their service for free Lower limit of normal (LLN) and Global Initiative for Chronic Obstructive Lung Disease (GOLD) criteria for diagnosing and grading airway obstruction were used Of 12448 participants in six congress cities 10395 (835) performed acceptable spirometry (mean age 510plusmn184 yrs 255 smokers 55 asthmatic) Airway obstruction was present in 124 of investigated subjects according to LLN criteria and 203 according to GOLD criteria Through multinomial logistic regression analysis age smoking habits and asthma were significant risk factors for airway obstruction Relative risk ratio and 95 confidence interval for LLN stage I for example was 29 (20-41) for the youngest age (le19 yrs) 19 (12-30) for the oldest age (ge80 yrs) 24 (20-29) for current smokers and 28 (22-36) for reported asthma diagnosis In addition to being a useful advocacy tool the spirometry tent represents an unusual occasion for early detection of airway obstruction in large numbers of city residents with an important public health perspective

Eur Respir J 2012 Jun39(6)1458-1467 Epub 2012 Jan 20

The European Respiratory Society spirometry tent a unique form of screening for airway obstruction

Maio S Sherrill DL Macnee W Lange P Costabel U Dahleacuten SE Sybrecht GW Burghuber OC Stevenson R Toslashnnesen P Haeussinger K Hedlin GBauer TT Riedler J Nicod L Carlsen KH Viegi G on behalf of the European Respiratory SocietyEuropean Lung Foundation Spirometry Tent working group

Abstract

In order to raise public awareness of the importance of early detection of airway obstruction and to enable many people who had not been tested previously to have their lung function measured the European Lung Foundation and the European Respiratory Society (ERS) organised a spirometry testing tent during the annual ERS Congresses in 2004-2009 Spirometry was performed during the ERS Congresses in volunteers all participants answered a simple brief questionnaire on their descriptive characteristics smoking and asthma Portable spirometers were freely provided by the manufacturer Nurses and doctors from pulmonary departments of local hospitalsuniversities gave their service for free Lower limit of normal (LLN) and Global Initiative for Chronic Obstructive Lung Disease (GOLD) criteria for diagnosing and grading airway obstruction were used Of 12448 participants in six congress cities 10395 (835) performed acceptable spirometry (mean age 510plusmn184 yrs 255 smokers 55 asthmatic) Airway obstruction was present in 124 of investigated subjects according to LLN criteria and 203 according to GOLD criteria Through multinomial logistic regression analysis age smoking habits and asthma were significant risk factors for airway obstruction Relative risk ratio and 95 confidence interval for LLN stage I for example was 29 (20-41) for the youngest age (le19 yrs) 19 (12-30) for the oldest age (ge80 yrs) 24 (20-29) for current smokers and 28 (22-36) for reported asthma diagnosis In addition to being a useful advocacy tool the spirometry tent represents an unusual occasion for early detection of airway obstruction in large numbers of city residents with an important public health perspective

Seccioacuten de Inmunologiacutea y Enfermedades Obstructivas

World COPD Day Activities Are they useful to detect lack of medical care and undertreatment in COPD patients

37 CIUDADES 8 CIUDADES

1265 SUJETOS

335

EPOC

World COPD Day Activities Are they useful to detect lack of

medical care and undertreatment in COPD patients Immunology and Obstructive Lung Diseases Scientific Section from Argentine Respiratory Medicine Association

FarmaEPOC

100 farmacias de la provincia de Barcelona realizaraacuten escalonadamente espirometriacuteas ambulatorias a personas con factores de riesgo hasta alcanzar una muestra de 3600 usuarios Las espirometriacuteas seraacuten evaluadas con una aplicacioacuten telemaacutetica que permite no soacutelo garantizar la calidad de las espirometriacuteas realizadas sino mantener una comunicacioacuten on-line entre la farmacia y los laboratorios de funcioacuten pulmonar del Hospital Cliacutenic y el Hospital de Sant Pau FarmaEPOC 2 tiene como objetivo confirmar los datos del estudio piloto FarmaEPOC 1 que concluye la viabilidad de la prueba de la espirometriacutea en la oficina de farmacia De este modo FarmaEPOC 2 da un paso maacutes y surge de la necesidad de conocer tanto las caracteriacutesticas epidemioloacutegicas de los usuarios con alteracioacuten del flujo aeacutereo cribados en farmacias Abandono del tabaco principal estrategia de intervencioacuten precoz

Dejar de fumar agrega antildeos de vida

Aba

ndon

o a

los

45-5

4 antilde

os

Fumadores No fumadores Abandono a los 45-54 antildeos

n=34439 meacutedicos britaacutenicos

Antildeos

de sobrevida

desde edad promedio de 50 antildeos

Abandono en promedio a los 50 antildeos

bull Disminuye la mortalidad (A) bull Disminuye declinacioacuten funcional bull La educacioacuten es central (A)

Doll et al BMJ 2004 328 1519-1527

Seccioacuten de Inmunologiacutea y Enfermedades Obstructivas

2011

External validation to COPD deteccion questionnaire

Bergna M Garcia G Grabre P Alchapar R Larrateguy L Altieri H

Figueroa Casas JC Zabert G Nannini L Pascanky D Fucile S

CuestionariO de Deteccioacuten de EPOC CODE

EDAD gt58 ANtildeOS

gt20 PAQUETESANtildeOS TOS CRONICA

FLEMA CROacuteNICA DISNEA ESFUERZO SEXO MASCULINO

BMIlt22

CON SOLO 3 Sensibilidad de 95 y un VPN del 96

CONCLUSIONES bull Para mejorar los resultados globales de la Epoc

debemos detectarla mas tempranamente

bull Actividades en la comunidad cuestionarios espirometria abreviada son herramientas que colaboran con estos objetivos

bull Detectando y confirmando la Epoc por espirometria nuestros pacientes tendran mas oportunidades

Recomendaciones para el Diagnoacutestico y Tratamiento de la Enfermedad Pulmonar Obstructiva Croacutenica EPOC

Muchas Graciashellip

  • ESTRATEGIAS DE LA DETECCION TEMPRANA DE EPOC
  • Como mejorar nuestro manejo y enfoque sobre EPOC
  • Nuacutemero de diapositiva 3
  • Nuacutemero de diapositiva 4
  • Nuacutemero de diapositiva 5
  • Nuacutemero de diapositiva 6
  • Diferencias en el financiamiento del NIH para enfermedades especiacuteficas en USA
  • Espirometriacutea herramienta clave
  • Espiroacutemetro - Tensioacutemetro
  • Nuacutemero de diapositiva 10
  • Nuacutemero de diapositiva 11
  • COPD - PS
  • COPD ndash Population Screener
  • Nuacutemero de diapositiva 14
  • Nuacutemero de diapositiva 15
  • Nuacutemero de diapositiva 16
  • Nuacutemero de diapositiva 17
  • Nuacutemero de diapositiva 18
  • IPAG International Primary Care Airways Guidelines
  • Plan de 3 pasos
  • Nuacutemero de diapositiva 21
  • Nuacutemero de diapositiva 22
  • Nuacutemero de diapositiva 23
  • Nuacutemero de diapositiva 24
  • Nuacutemero de diapositiva 25
  • Eur Respir J 2012 Jun39(6)1458-1467 Epub 2012 Jan 20The European Respiratory Society spirometry tent a unique form of screening for airway obstruction
  • Eur Respir J 2012 Jun39(6)1458-1467 Epub 2012 Jan 20The European Respiratory Society spirometry tent a unique form of screening for airway obstruction
  • Nuacutemero de diapositiva 28
  • Nuacutemero de diapositiva 29
  • 13World COPD Day Activities Are they useful to detect lack of medical care and undertreatment in COPD patients13Immunology and Obstructive Lung Diseases Scientific Section from Argentine Respiratory Medicine Association
  • FarmaEPOC
  • Nuacutemero de diapositiva 32
  • Dejar de fumar agrega antildeos de vida
  • Nuacutemero de diapositiva 34
  • Nuacutemero de diapositiva 35
  • Nuacutemero de diapositiva 36
  • CONCLUSIONES
  • Nuacutemero de diapositiva 38

Diferencias en el financiamiento del NIH para enfermedades especiacuteficas en USA

-100

-50

0

50

100

150

200

250

300

EPOC Neumoniacutea

Ca Pulmoacuten Asma

Cirrosis Cardiopatiacutea isqueacutemica

Diabetes Demencia

Ca Mama

SIDA 1287

Mill

ones

($)

Sobr

efin

anci

amie

nto

Subf

inan

ciam

ient

o

Gross CP et al NEJM 1999

Espirometriacutea herramienta clave

Tres fases

1 Inspiracioacuten maacutexima(maacutexima

capacidad)

2 ldquoSoplarrdquo con el maacuteximo esfuerzo

3 Y continuar exhalando hasta que no haya aire en los pulmones espiracioacuten de 6 segundos como miacutenimo

3 esfuerzos no maacutes de 8

Espiroacutemetro - Tensioacutemetro

EPOC ndash Hipertensioacuten arterial

Es posible hacer Diagnoacutestico Temprana

en la EPOC (Antes que los

siacutentomas)

COPD - PS

COPD ndash Population Screener

IPAG International Primary Care Airways Guidelines

Plan de 3 pasos

Eur Respir J 2012 Jun39(6)1458-1467 Epub 2012 Jan 20

The European Respiratory Society spirometry tent a unique form of screening for airway obstruction

Maio S Sherrill DL Macnee W Lange P Costabel U Dahleacuten SE Sybrecht GW Burghuber OC Stevenson R Toslashnnesen P Haeussinger K Hedlin GBauer TT Riedler J Nicod L Carlsen KH Viegi G on behalf of the European Respiratory SocietyEuropean Lung Foundation Spirometry Tent working group

Abstract

In order to raise public awareness of the importance of early detection of airway obstruction and to enable many people who had not been tested previously to have their lung function measured the European Lung Foundation and the European Respiratory Society (ERS) organised a spirometry testing tent during the annual ERS Congresses in 2004-2009 Spirometry was performed during the ERS Congresses in volunteers all participants answered a simple brief questionnaire on their descriptive characteristics smoking and asthma Portable spirometers were freely provided by the manufacturer Nurses and doctors from pulmonary departments of local hospitalsuniversities gave their service for free Lower limit of normal (LLN) and Global Initiative for Chronic Obstructive Lung Disease (GOLD) criteria for diagnosing and grading airway obstruction were used Of 12448 participants in six congress cities 10395 (835) performed acceptable spirometry (mean age 510plusmn184 yrs 255 smokers 55 asthmatic) Airway obstruction was present in 124 of investigated subjects according to LLN criteria and 203 according to GOLD criteria Through multinomial logistic regression analysis age smoking habits and asthma were significant risk factors for airway obstruction Relative risk ratio and 95 confidence interval for LLN stage I for example was 29 (20-41) for the youngest age (le19 yrs) 19 (12-30) for the oldest age (ge80 yrs) 24 (20-29) for current smokers and 28 (22-36) for reported asthma diagnosis In addition to being a useful advocacy tool the spirometry tent represents an unusual occasion for early detection of airway obstruction in large numbers of city residents with an important public health perspective

Eur Respir J 2012 Jun39(6)1458-1467 Epub 2012 Jan 20

The European Respiratory Society spirometry tent a unique form of screening for airway obstruction

Maio S Sherrill DL Macnee W Lange P Costabel U Dahleacuten SE Sybrecht GW Burghuber OC Stevenson R Toslashnnesen P Haeussinger K Hedlin GBauer TT Riedler J Nicod L Carlsen KH Viegi G on behalf of the European Respiratory SocietyEuropean Lung Foundation Spirometry Tent working group

Abstract

In order to raise public awareness of the importance of early detection of airway obstruction and to enable many people who had not been tested previously to have their lung function measured the European Lung Foundation and the European Respiratory Society (ERS) organised a spirometry testing tent during the annual ERS Congresses in 2004-2009 Spirometry was performed during the ERS Congresses in volunteers all participants answered a simple brief questionnaire on their descriptive characteristics smoking and asthma Portable spirometers were freely provided by the manufacturer Nurses and doctors from pulmonary departments of local hospitalsuniversities gave their service for free Lower limit of normal (LLN) and Global Initiative for Chronic Obstructive Lung Disease (GOLD) criteria for diagnosing and grading airway obstruction were used Of 12448 participants in six congress cities 10395 (835) performed acceptable spirometry (mean age 510plusmn184 yrs 255 smokers 55 asthmatic) Airway obstruction was present in 124 of investigated subjects according to LLN criteria and 203 according to GOLD criteria Through multinomial logistic regression analysis age smoking habits and asthma were significant risk factors for airway obstruction Relative risk ratio and 95 confidence interval for LLN stage I for example was 29 (20-41) for the youngest age (le19 yrs) 19 (12-30) for the oldest age (ge80 yrs) 24 (20-29) for current smokers and 28 (22-36) for reported asthma diagnosis In addition to being a useful advocacy tool the spirometry tent represents an unusual occasion for early detection of airway obstruction in large numbers of city residents with an important public health perspective

Seccioacuten de Inmunologiacutea y Enfermedades Obstructivas

World COPD Day Activities Are they useful to detect lack of medical care and undertreatment in COPD patients

37 CIUDADES 8 CIUDADES

1265 SUJETOS

335

EPOC

World COPD Day Activities Are they useful to detect lack of

medical care and undertreatment in COPD patients Immunology and Obstructive Lung Diseases Scientific Section from Argentine Respiratory Medicine Association

FarmaEPOC

100 farmacias de la provincia de Barcelona realizaraacuten escalonadamente espirometriacuteas ambulatorias a personas con factores de riesgo hasta alcanzar una muestra de 3600 usuarios Las espirometriacuteas seraacuten evaluadas con una aplicacioacuten telemaacutetica que permite no soacutelo garantizar la calidad de las espirometriacuteas realizadas sino mantener una comunicacioacuten on-line entre la farmacia y los laboratorios de funcioacuten pulmonar del Hospital Cliacutenic y el Hospital de Sant Pau FarmaEPOC 2 tiene como objetivo confirmar los datos del estudio piloto FarmaEPOC 1 que concluye la viabilidad de la prueba de la espirometriacutea en la oficina de farmacia De este modo FarmaEPOC 2 da un paso maacutes y surge de la necesidad de conocer tanto las caracteriacutesticas epidemioloacutegicas de los usuarios con alteracioacuten del flujo aeacutereo cribados en farmacias Abandono del tabaco principal estrategia de intervencioacuten precoz

Dejar de fumar agrega antildeos de vida

Aba

ndon

o a

los

45-5

4 antilde

os

Fumadores No fumadores Abandono a los 45-54 antildeos

n=34439 meacutedicos britaacutenicos

Antildeos

de sobrevida

desde edad promedio de 50 antildeos

Abandono en promedio a los 50 antildeos

bull Disminuye la mortalidad (A) bull Disminuye declinacioacuten funcional bull La educacioacuten es central (A)

Doll et al BMJ 2004 328 1519-1527

Seccioacuten de Inmunologiacutea y Enfermedades Obstructivas

2011

External validation to COPD deteccion questionnaire

Bergna M Garcia G Grabre P Alchapar R Larrateguy L Altieri H

Figueroa Casas JC Zabert G Nannini L Pascanky D Fucile S

CuestionariO de Deteccioacuten de EPOC CODE

EDAD gt58 ANtildeOS

gt20 PAQUETESANtildeOS TOS CRONICA

FLEMA CROacuteNICA DISNEA ESFUERZO SEXO MASCULINO

BMIlt22

CON SOLO 3 Sensibilidad de 95 y un VPN del 96

CONCLUSIONES bull Para mejorar los resultados globales de la Epoc

debemos detectarla mas tempranamente

bull Actividades en la comunidad cuestionarios espirometria abreviada son herramientas que colaboran con estos objetivos

bull Detectando y confirmando la Epoc por espirometria nuestros pacientes tendran mas oportunidades

Recomendaciones para el Diagnoacutestico y Tratamiento de la Enfermedad Pulmonar Obstructiva Croacutenica EPOC

Muchas Graciashellip

  • ESTRATEGIAS DE LA DETECCION TEMPRANA DE EPOC
  • Como mejorar nuestro manejo y enfoque sobre EPOC
  • Nuacutemero de diapositiva 3
  • Nuacutemero de diapositiva 4
  • Nuacutemero de diapositiva 5
  • Nuacutemero de diapositiva 6
  • Diferencias en el financiamiento del NIH para enfermedades especiacuteficas en USA
  • Espirometriacutea herramienta clave
  • Espiroacutemetro - Tensioacutemetro
  • Nuacutemero de diapositiva 10
  • Nuacutemero de diapositiva 11
  • COPD - PS
  • COPD ndash Population Screener
  • Nuacutemero de diapositiva 14
  • Nuacutemero de diapositiva 15
  • Nuacutemero de diapositiva 16
  • Nuacutemero de diapositiva 17
  • Nuacutemero de diapositiva 18
  • IPAG International Primary Care Airways Guidelines
  • Plan de 3 pasos
  • Nuacutemero de diapositiva 21
  • Nuacutemero de diapositiva 22
  • Nuacutemero de diapositiva 23
  • Nuacutemero de diapositiva 24
  • Nuacutemero de diapositiva 25
  • Eur Respir J 2012 Jun39(6)1458-1467 Epub 2012 Jan 20The European Respiratory Society spirometry tent a unique form of screening for airway obstruction
  • Eur Respir J 2012 Jun39(6)1458-1467 Epub 2012 Jan 20The European Respiratory Society spirometry tent a unique form of screening for airway obstruction
  • Nuacutemero de diapositiva 28
  • Nuacutemero de diapositiva 29
  • 13World COPD Day Activities Are they useful to detect lack of medical care and undertreatment in COPD patients13Immunology and Obstructive Lung Diseases Scientific Section from Argentine Respiratory Medicine Association
  • FarmaEPOC
  • Nuacutemero de diapositiva 32
  • Dejar de fumar agrega antildeos de vida
  • Nuacutemero de diapositiva 34
  • Nuacutemero de diapositiva 35
  • Nuacutemero de diapositiva 36
  • CONCLUSIONES
  • Nuacutemero de diapositiva 38

Espirometriacutea herramienta clave

Tres fases

1 Inspiracioacuten maacutexima(maacutexima

capacidad)

2 ldquoSoplarrdquo con el maacuteximo esfuerzo

3 Y continuar exhalando hasta que no haya aire en los pulmones espiracioacuten de 6 segundos como miacutenimo

3 esfuerzos no maacutes de 8

Espiroacutemetro - Tensioacutemetro

EPOC ndash Hipertensioacuten arterial

Es posible hacer Diagnoacutestico Temprana

en la EPOC (Antes que los

siacutentomas)

COPD - PS

COPD ndash Population Screener

IPAG International Primary Care Airways Guidelines

Plan de 3 pasos

Eur Respir J 2012 Jun39(6)1458-1467 Epub 2012 Jan 20

The European Respiratory Society spirometry tent a unique form of screening for airway obstruction

Maio S Sherrill DL Macnee W Lange P Costabel U Dahleacuten SE Sybrecht GW Burghuber OC Stevenson R Toslashnnesen P Haeussinger K Hedlin GBauer TT Riedler J Nicod L Carlsen KH Viegi G on behalf of the European Respiratory SocietyEuropean Lung Foundation Spirometry Tent working group

Abstract

In order to raise public awareness of the importance of early detection of airway obstruction and to enable many people who had not been tested previously to have their lung function measured the European Lung Foundation and the European Respiratory Society (ERS) organised a spirometry testing tent during the annual ERS Congresses in 2004-2009 Spirometry was performed during the ERS Congresses in volunteers all participants answered a simple brief questionnaire on their descriptive characteristics smoking and asthma Portable spirometers were freely provided by the manufacturer Nurses and doctors from pulmonary departments of local hospitalsuniversities gave their service for free Lower limit of normal (LLN) and Global Initiative for Chronic Obstructive Lung Disease (GOLD) criteria for diagnosing and grading airway obstruction were used Of 12448 participants in six congress cities 10395 (835) performed acceptable spirometry (mean age 510plusmn184 yrs 255 smokers 55 asthmatic) Airway obstruction was present in 124 of investigated subjects according to LLN criteria and 203 according to GOLD criteria Through multinomial logistic regression analysis age smoking habits and asthma were significant risk factors for airway obstruction Relative risk ratio and 95 confidence interval for LLN stage I for example was 29 (20-41) for the youngest age (le19 yrs) 19 (12-30) for the oldest age (ge80 yrs) 24 (20-29) for current smokers and 28 (22-36) for reported asthma diagnosis In addition to being a useful advocacy tool the spirometry tent represents an unusual occasion for early detection of airway obstruction in large numbers of city residents with an important public health perspective

Eur Respir J 2012 Jun39(6)1458-1467 Epub 2012 Jan 20

The European Respiratory Society spirometry tent a unique form of screening for airway obstruction

Maio S Sherrill DL Macnee W Lange P Costabel U Dahleacuten SE Sybrecht GW Burghuber OC Stevenson R Toslashnnesen P Haeussinger K Hedlin GBauer TT Riedler J Nicod L Carlsen KH Viegi G on behalf of the European Respiratory SocietyEuropean Lung Foundation Spirometry Tent working group

Abstract

In order to raise public awareness of the importance of early detection of airway obstruction and to enable many people who had not been tested previously to have their lung function measured the European Lung Foundation and the European Respiratory Society (ERS) organised a spirometry testing tent during the annual ERS Congresses in 2004-2009 Spirometry was performed during the ERS Congresses in volunteers all participants answered a simple brief questionnaire on their descriptive characteristics smoking and asthma Portable spirometers were freely provided by the manufacturer Nurses and doctors from pulmonary departments of local hospitalsuniversities gave their service for free Lower limit of normal (LLN) and Global Initiative for Chronic Obstructive Lung Disease (GOLD) criteria for diagnosing and grading airway obstruction were used Of 12448 participants in six congress cities 10395 (835) performed acceptable spirometry (mean age 510plusmn184 yrs 255 smokers 55 asthmatic) Airway obstruction was present in 124 of investigated subjects according to LLN criteria and 203 according to GOLD criteria Through multinomial logistic regression analysis age smoking habits and asthma were significant risk factors for airway obstruction Relative risk ratio and 95 confidence interval for LLN stage I for example was 29 (20-41) for the youngest age (le19 yrs) 19 (12-30) for the oldest age (ge80 yrs) 24 (20-29) for current smokers and 28 (22-36) for reported asthma diagnosis In addition to being a useful advocacy tool the spirometry tent represents an unusual occasion for early detection of airway obstruction in large numbers of city residents with an important public health perspective

Seccioacuten de Inmunologiacutea y Enfermedades Obstructivas

World COPD Day Activities Are they useful to detect lack of medical care and undertreatment in COPD patients

37 CIUDADES 8 CIUDADES

1265 SUJETOS

335

EPOC

World COPD Day Activities Are they useful to detect lack of

medical care and undertreatment in COPD patients Immunology and Obstructive Lung Diseases Scientific Section from Argentine Respiratory Medicine Association

FarmaEPOC

100 farmacias de la provincia de Barcelona realizaraacuten escalonadamente espirometriacuteas ambulatorias a personas con factores de riesgo hasta alcanzar una muestra de 3600 usuarios Las espirometriacuteas seraacuten evaluadas con una aplicacioacuten telemaacutetica que permite no soacutelo garantizar la calidad de las espirometriacuteas realizadas sino mantener una comunicacioacuten on-line entre la farmacia y los laboratorios de funcioacuten pulmonar del Hospital Cliacutenic y el Hospital de Sant Pau FarmaEPOC 2 tiene como objetivo confirmar los datos del estudio piloto FarmaEPOC 1 que concluye la viabilidad de la prueba de la espirometriacutea en la oficina de farmacia De este modo FarmaEPOC 2 da un paso maacutes y surge de la necesidad de conocer tanto las caracteriacutesticas epidemioloacutegicas de los usuarios con alteracioacuten del flujo aeacutereo cribados en farmacias Abandono del tabaco principal estrategia de intervencioacuten precoz

Dejar de fumar agrega antildeos de vida

Aba

ndon

o a

los

45-5

4 antilde

os

Fumadores No fumadores Abandono a los 45-54 antildeos

n=34439 meacutedicos britaacutenicos

Antildeos

de sobrevida

desde edad promedio de 50 antildeos

Abandono en promedio a los 50 antildeos

bull Disminuye la mortalidad (A) bull Disminuye declinacioacuten funcional bull La educacioacuten es central (A)

Doll et al BMJ 2004 328 1519-1527

Seccioacuten de Inmunologiacutea y Enfermedades Obstructivas

2011

External validation to COPD deteccion questionnaire

Bergna M Garcia G Grabre P Alchapar R Larrateguy L Altieri H

Figueroa Casas JC Zabert G Nannini L Pascanky D Fucile S

CuestionariO de Deteccioacuten de EPOC CODE

EDAD gt58 ANtildeOS

gt20 PAQUETESANtildeOS TOS CRONICA

FLEMA CROacuteNICA DISNEA ESFUERZO SEXO MASCULINO

BMIlt22

CON SOLO 3 Sensibilidad de 95 y un VPN del 96

CONCLUSIONES bull Para mejorar los resultados globales de la Epoc

debemos detectarla mas tempranamente

bull Actividades en la comunidad cuestionarios espirometria abreviada son herramientas que colaboran con estos objetivos

bull Detectando y confirmando la Epoc por espirometria nuestros pacientes tendran mas oportunidades

Recomendaciones para el Diagnoacutestico y Tratamiento de la Enfermedad Pulmonar Obstructiva Croacutenica EPOC

Muchas Graciashellip

  • ESTRATEGIAS DE LA DETECCION TEMPRANA DE EPOC
  • Como mejorar nuestro manejo y enfoque sobre EPOC
  • Nuacutemero de diapositiva 3
  • Nuacutemero de diapositiva 4
  • Nuacutemero de diapositiva 5
  • Nuacutemero de diapositiva 6
  • Diferencias en el financiamiento del NIH para enfermedades especiacuteficas en USA
  • Espirometriacutea herramienta clave
  • Espiroacutemetro - Tensioacutemetro
  • Nuacutemero de diapositiva 10
  • Nuacutemero de diapositiva 11
  • COPD - PS
  • COPD ndash Population Screener
  • Nuacutemero de diapositiva 14
  • Nuacutemero de diapositiva 15
  • Nuacutemero de diapositiva 16
  • Nuacutemero de diapositiva 17
  • Nuacutemero de diapositiva 18
  • IPAG International Primary Care Airways Guidelines
  • Plan de 3 pasos
  • Nuacutemero de diapositiva 21
  • Nuacutemero de diapositiva 22
  • Nuacutemero de diapositiva 23
  • Nuacutemero de diapositiva 24
  • Nuacutemero de diapositiva 25
  • Eur Respir J 2012 Jun39(6)1458-1467 Epub 2012 Jan 20The European Respiratory Society spirometry tent a unique form of screening for airway obstruction
  • Eur Respir J 2012 Jun39(6)1458-1467 Epub 2012 Jan 20The European Respiratory Society spirometry tent a unique form of screening for airway obstruction
  • Nuacutemero de diapositiva 28
  • Nuacutemero de diapositiva 29
  • 13World COPD Day Activities Are they useful to detect lack of medical care and undertreatment in COPD patients13Immunology and Obstructive Lung Diseases Scientific Section from Argentine Respiratory Medicine Association
  • FarmaEPOC
  • Nuacutemero de diapositiva 32
  • Dejar de fumar agrega antildeos de vida
  • Nuacutemero de diapositiva 34
  • Nuacutemero de diapositiva 35
  • Nuacutemero de diapositiva 36
  • CONCLUSIONES
  • Nuacutemero de diapositiva 38

Espiroacutemetro - Tensioacutemetro

EPOC ndash Hipertensioacuten arterial

Es posible hacer Diagnoacutestico Temprana

en la EPOC (Antes que los

siacutentomas)

COPD - PS

COPD ndash Population Screener

IPAG International Primary Care Airways Guidelines

Plan de 3 pasos

Eur Respir J 2012 Jun39(6)1458-1467 Epub 2012 Jan 20

The European Respiratory Society spirometry tent a unique form of screening for airway obstruction

Maio S Sherrill DL Macnee W Lange P Costabel U Dahleacuten SE Sybrecht GW Burghuber OC Stevenson R Toslashnnesen P Haeussinger K Hedlin GBauer TT Riedler J Nicod L Carlsen KH Viegi G on behalf of the European Respiratory SocietyEuropean Lung Foundation Spirometry Tent working group

Abstract

In order to raise public awareness of the importance of early detection of airway obstruction and to enable many people who had not been tested previously to have their lung function measured the European Lung Foundation and the European Respiratory Society (ERS) organised a spirometry testing tent during the annual ERS Congresses in 2004-2009 Spirometry was performed during the ERS Congresses in volunteers all participants answered a simple brief questionnaire on their descriptive characteristics smoking and asthma Portable spirometers were freely provided by the manufacturer Nurses and doctors from pulmonary departments of local hospitalsuniversities gave their service for free Lower limit of normal (LLN) and Global Initiative for Chronic Obstructive Lung Disease (GOLD) criteria for diagnosing and grading airway obstruction were used Of 12448 participants in six congress cities 10395 (835) performed acceptable spirometry (mean age 510plusmn184 yrs 255 smokers 55 asthmatic) Airway obstruction was present in 124 of investigated subjects according to LLN criteria and 203 according to GOLD criteria Through multinomial logistic regression analysis age smoking habits and asthma were significant risk factors for airway obstruction Relative risk ratio and 95 confidence interval for LLN stage I for example was 29 (20-41) for the youngest age (le19 yrs) 19 (12-30) for the oldest age (ge80 yrs) 24 (20-29) for current smokers and 28 (22-36) for reported asthma diagnosis In addition to being a useful advocacy tool the spirometry tent represents an unusual occasion for early detection of airway obstruction in large numbers of city residents with an important public health perspective

Eur Respir J 2012 Jun39(6)1458-1467 Epub 2012 Jan 20

The European Respiratory Society spirometry tent a unique form of screening for airway obstruction

Maio S Sherrill DL Macnee W Lange P Costabel U Dahleacuten SE Sybrecht GW Burghuber OC Stevenson R Toslashnnesen P Haeussinger K Hedlin GBauer TT Riedler J Nicod L Carlsen KH Viegi G on behalf of the European Respiratory SocietyEuropean Lung Foundation Spirometry Tent working group

Abstract

In order to raise public awareness of the importance of early detection of airway obstruction and to enable many people who had not been tested previously to have their lung function measured the European Lung Foundation and the European Respiratory Society (ERS) organised a spirometry testing tent during the annual ERS Congresses in 2004-2009 Spirometry was performed during the ERS Congresses in volunteers all participants answered a simple brief questionnaire on their descriptive characteristics smoking and asthma Portable spirometers were freely provided by the manufacturer Nurses and doctors from pulmonary departments of local hospitalsuniversities gave their service for free Lower limit of normal (LLN) and Global Initiative for Chronic Obstructive Lung Disease (GOLD) criteria for diagnosing and grading airway obstruction were used Of 12448 participants in six congress cities 10395 (835) performed acceptable spirometry (mean age 510plusmn184 yrs 255 smokers 55 asthmatic) Airway obstruction was present in 124 of investigated subjects according to LLN criteria and 203 according to GOLD criteria Through multinomial logistic regression analysis age smoking habits and asthma were significant risk factors for airway obstruction Relative risk ratio and 95 confidence interval for LLN stage I for example was 29 (20-41) for the youngest age (le19 yrs) 19 (12-30) for the oldest age (ge80 yrs) 24 (20-29) for current smokers and 28 (22-36) for reported asthma diagnosis In addition to being a useful advocacy tool the spirometry tent represents an unusual occasion for early detection of airway obstruction in large numbers of city residents with an important public health perspective

Seccioacuten de Inmunologiacutea y Enfermedades Obstructivas

World COPD Day Activities Are they useful to detect lack of medical care and undertreatment in COPD patients

37 CIUDADES 8 CIUDADES

1265 SUJETOS

335

EPOC

World COPD Day Activities Are they useful to detect lack of

medical care and undertreatment in COPD patients Immunology and Obstructive Lung Diseases Scientific Section from Argentine Respiratory Medicine Association

FarmaEPOC

100 farmacias de la provincia de Barcelona realizaraacuten escalonadamente espirometriacuteas ambulatorias a personas con factores de riesgo hasta alcanzar una muestra de 3600 usuarios Las espirometriacuteas seraacuten evaluadas con una aplicacioacuten telemaacutetica que permite no soacutelo garantizar la calidad de las espirometriacuteas realizadas sino mantener una comunicacioacuten on-line entre la farmacia y los laboratorios de funcioacuten pulmonar del Hospital Cliacutenic y el Hospital de Sant Pau FarmaEPOC 2 tiene como objetivo confirmar los datos del estudio piloto FarmaEPOC 1 que concluye la viabilidad de la prueba de la espirometriacutea en la oficina de farmacia De este modo FarmaEPOC 2 da un paso maacutes y surge de la necesidad de conocer tanto las caracteriacutesticas epidemioloacutegicas de los usuarios con alteracioacuten del flujo aeacutereo cribados en farmacias Abandono del tabaco principal estrategia de intervencioacuten precoz

Dejar de fumar agrega antildeos de vida

Aba

ndon

o a

los

45-5

4 antilde

os

Fumadores No fumadores Abandono a los 45-54 antildeos

n=34439 meacutedicos britaacutenicos

Antildeos

de sobrevida

desde edad promedio de 50 antildeos

Abandono en promedio a los 50 antildeos

bull Disminuye la mortalidad (A) bull Disminuye declinacioacuten funcional bull La educacioacuten es central (A)

Doll et al BMJ 2004 328 1519-1527

Seccioacuten de Inmunologiacutea y Enfermedades Obstructivas

2011

External validation to COPD deteccion questionnaire

Bergna M Garcia G Grabre P Alchapar R Larrateguy L Altieri H

Figueroa Casas JC Zabert G Nannini L Pascanky D Fucile S

CuestionariO de Deteccioacuten de EPOC CODE

EDAD gt58 ANtildeOS

gt20 PAQUETESANtildeOS TOS CRONICA

FLEMA CROacuteNICA DISNEA ESFUERZO SEXO MASCULINO

BMIlt22

CON SOLO 3 Sensibilidad de 95 y un VPN del 96

CONCLUSIONES bull Para mejorar los resultados globales de la Epoc

debemos detectarla mas tempranamente

bull Actividades en la comunidad cuestionarios espirometria abreviada son herramientas que colaboran con estos objetivos

bull Detectando y confirmando la Epoc por espirometria nuestros pacientes tendran mas oportunidades

Recomendaciones para el Diagnoacutestico y Tratamiento de la Enfermedad Pulmonar Obstructiva Croacutenica EPOC

Muchas Graciashellip

  • ESTRATEGIAS DE LA DETECCION TEMPRANA DE EPOC
  • Como mejorar nuestro manejo y enfoque sobre EPOC
  • Nuacutemero de diapositiva 3
  • Nuacutemero de diapositiva 4
  • Nuacutemero de diapositiva 5
  • Nuacutemero de diapositiva 6
  • Diferencias en el financiamiento del NIH para enfermedades especiacuteficas en USA
  • Espirometriacutea herramienta clave
  • Espiroacutemetro - Tensioacutemetro
  • Nuacutemero de diapositiva 10
  • Nuacutemero de diapositiva 11
  • COPD - PS
  • COPD ndash Population Screener
  • Nuacutemero de diapositiva 14
  • Nuacutemero de diapositiva 15
  • Nuacutemero de diapositiva 16
  • Nuacutemero de diapositiva 17
  • Nuacutemero de diapositiva 18
  • IPAG International Primary Care Airways Guidelines
  • Plan de 3 pasos
  • Nuacutemero de diapositiva 21
  • Nuacutemero de diapositiva 22
  • Nuacutemero de diapositiva 23
  • Nuacutemero de diapositiva 24
  • Nuacutemero de diapositiva 25
  • Eur Respir J 2012 Jun39(6)1458-1467 Epub 2012 Jan 20The European Respiratory Society spirometry tent a unique form of screening for airway obstruction
  • Eur Respir J 2012 Jun39(6)1458-1467 Epub 2012 Jan 20The European Respiratory Society spirometry tent a unique form of screening for airway obstruction
  • Nuacutemero de diapositiva 28
  • Nuacutemero de diapositiva 29
  • 13World COPD Day Activities Are they useful to detect lack of medical care and undertreatment in COPD patients13Immunology and Obstructive Lung Diseases Scientific Section from Argentine Respiratory Medicine Association
  • FarmaEPOC
  • Nuacutemero de diapositiva 32
  • Dejar de fumar agrega antildeos de vida
  • Nuacutemero de diapositiva 34
  • Nuacutemero de diapositiva 35
  • Nuacutemero de diapositiva 36
  • CONCLUSIONES
  • Nuacutemero de diapositiva 38

Es posible hacer Diagnoacutestico Temprana

en la EPOC (Antes que los

siacutentomas)

COPD - PS

COPD ndash Population Screener

IPAG International Primary Care Airways Guidelines

Plan de 3 pasos

Eur Respir J 2012 Jun39(6)1458-1467 Epub 2012 Jan 20

The European Respiratory Society spirometry tent a unique form of screening for airway obstruction

Maio S Sherrill DL Macnee W Lange P Costabel U Dahleacuten SE Sybrecht GW Burghuber OC Stevenson R Toslashnnesen P Haeussinger K Hedlin GBauer TT Riedler J Nicod L Carlsen KH Viegi G on behalf of the European Respiratory SocietyEuropean Lung Foundation Spirometry Tent working group

Abstract

In order to raise public awareness of the importance of early detection of airway obstruction and to enable many people who had not been tested previously to have their lung function measured the European Lung Foundation and the European Respiratory Society (ERS) organised a spirometry testing tent during the annual ERS Congresses in 2004-2009 Spirometry was performed during the ERS Congresses in volunteers all participants answered a simple brief questionnaire on their descriptive characteristics smoking and asthma Portable spirometers were freely provided by the manufacturer Nurses and doctors from pulmonary departments of local hospitalsuniversities gave their service for free Lower limit of normal (LLN) and Global Initiative for Chronic Obstructive Lung Disease (GOLD) criteria for diagnosing and grading airway obstruction were used Of 12448 participants in six congress cities 10395 (835) performed acceptable spirometry (mean age 510plusmn184 yrs 255 smokers 55 asthmatic) Airway obstruction was present in 124 of investigated subjects according to LLN criteria and 203 according to GOLD criteria Through multinomial logistic regression analysis age smoking habits and asthma were significant risk factors for airway obstruction Relative risk ratio and 95 confidence interval for LLN stage I for example was 29 (20-41) for the youngest age (le19 yrs) 19 (12-30) for the oldest age (ge80 yrs) 24 (20-29) for current smokers and 28 (22-36) for reported asthma diagnosis In addition to being a useful advocacy tool the spirometry tent represents an unusual occasion for early detection of airway obstruction in large numbers of city residents with an important public health perspective

Eur Respir J 2012 Jun39(6)1458-1467 Epub 2012 Jan 20

The European Respiratory Society spirometry tent a unique form of screening for airway obstruction

Maio S Sherrill DL Macnee W Lange P Costabel U Dahleacuten SE Sybrecht GW Burghuber OC Stevenson R Toslashnnesen P Haeussinger K Hedlin GBauer TT Riedler J Nicod L Carlsen KH Viegi G on behalf of the European Respiratory SocietyEuropean Lung Foundation Spirometry Tent working group

Abstract

In order to raise public awareness of the importance of early detection of airway obstruction and to enable many people who had not been tested previously to have their lung function measured the European Lung Foundation and the European Respiratory Society (ERS) organised a spirometry testing tent during the annual ERS Congresses in 2004-2009 Spirometry was performed during the ERS Congresses in volunteers all participants answered a simple brief questionnaire on their descriptive characteristics smoking and asthma Portable spirometers were freely provided by the manufacturer Nurses and doctors from pulmonary departments of local hospitalsuniversities gave their service for free Lower limit of normal (LLN) and Global Initiative for Chronic Obstructive Lung Disease (GOLD) criteria for diagnosing and grading airway obstruction were used Of 12448 participants in six congress cities 10395 (835) performed acceptable spirometry (mean age 510plusmn184 yrs 255 smokers 55 asthmatic) Airway obstruction was present in 124 of investigated subjects according to LLN criteria and 203 according to GOLD criteria Through multinomial logistic regression analysis age smoking habits and asthma were significant risk factors for airway obstruction Relative risk ratio and 95 confidence interval for LLN stage I for example was 29 (20-41) for the youngest age (le19 yrs) 19 (12-30) for the oldest age (ge80 yrs) 24 (20-29) for current smokers and 28 (22-36) for reported asthma diagnosis In addition to being a useful advocacy tool the spirometry tent represents an unusual occasion for early detection of airway obstruction in large numbers of city residents with an important public health perspective

Seccioacuten de Inmunologiacutea y Enfermedades Obstructivas

World COPD Day Activities Are they useful to detect lack of medical care and undertreatment in COPD patients

37 CIUDADES 8 CIUDADES

1265 SUJETOS

335

EPOC

World COPD Day Activities Are they useful to detect lack of

medical care and undertreatment in COPD patients Immunology and Obstructive Lung Diseases Scientific Section from Argentine Respiratory Medicine Association

FarmaEPOC

100 farmacias de la provincia de Barcelona realizaraacuten escalonadamente espirometriacuteas ambulatorias a personas con factores de riesgo hasta alcanzar una muestra de 3600 usuarios Las espirometriacuteas seraacuten evaluadas con una aplicacioacuten telemaacutetica que permite no soacutelo garantizar la calidad de las espirometriacuteas realizadas sino mantener una comunicacioacuten on-line entre la farmacia y los laboratorios de funcioacuten pulmonar del Hospital Cliacutenic y el Hospital de Sant Pau FarmaEPOC 2 tiene como objetivo confirmar los datos del estudio piloto FarmaEPOC 1 que concluye la viabilidad de la prueba de la espirometriacutea en la oficina de farmacia De este modo FarmaEPOC 2 da un paso maacutes y surge de la necesidad de conocer tanto las caracteriacutesticas epidemioloacutegicas de los usuarios con alteracioacuten del flujo aeacutereo cribados en farmacias Abandono del tabaco principal estrategia de intervencioacuten precoz

Dejar de fumar agrega antildeos de vida

Aba

ndon

o a

los

45-5

4 antilde

os

Fumadores No fumadores Abandono a los 45-54 antildeos

n=34439 meacutedicos britaacutenicos

Antildeos

de sobrevida

desde edad promedio de 50 antildeos

Abandono en promedio a los 50 antildeos

bull Disminuye la mortalidad (A) bull Disminuye declinacioacuten funcional bull La educacioacuten es central (A)

Doll et al BMJ 2004 328 1519-1527

Seccioacuten de Inmunologiacutea y Enfermedades Obstructivas

2011

External validation to COPD deteccion questionnaire

Bergna M Garcia G Grabre P Alchapar R Larrateguy L Altieri H

Figueroa Casas JC Zabert G Nannini L Pascanky D Fucile S

CuestionariO de Deteccioacuten de EPOC CODE

EDAD gt58 ANtildeOS

gt20 PAQUETESANtildeOS TOS CRONICA

FLEMA CROacuteNICA DISNEA ESFUERZO SEXO MASCULINO

BMIlt22

CON SOLO 3 Sensibilidad de 95 y un VPN del 96

CONCLUSIONES bull Para mejorar los resultados globales de la Epoc

debemos detectarla mas tempranamente

bull Actividades en la comunidad cuestionarios espirometria abreviada son herramientas que colaboran con estos objetivos

bull Detectando y confirmando la Epoc por espirometria nuestros pacientes tendran mas oportunidades

Recomendaciones para el Diagnoacutestico y Tratamiento de la Enfermedad Pulmonar Obstructiva Croacutenica EPOC

Muchas Graciashellip

  • ESTRATEGIAS DE LA DETECCION TEMPRANA DE EPOC
  • Como mejorar nuestro manejo y enfoque sobre EPOC
  • Nuacutemero de diapositiva 3
  • Nuacutemero de diapositiva 4
  • Nuacutemero de diapositiva 5
  • Nuacutemero de diapositiva 6
  • Diferencias en el financiamiento del NIH para enfermedades especiacuteficas en USA
  • Espirometriacutea herramienta clave
  • Espiroacutemetro - Tensioacutemetro
  • Nuacutemero de diapositiva 10
  • Nuacutemero de diapositiva 11
  • COPD - PS
  • COPD ndash Population Screener
  • Nuacutemero de diapositiva 14
  • Nuacutemero de diapositiva 15
  • Nuacutemero de diapositiva 16
  • Nuacutemero de diapositiva 17
  • Nuacutemero de diapositiva 18
  • IPAG International Primary Care Airways Guidelines
  • Plan de 3 pasos
  • Nuacutemero de diapositiva 21
  • Nuacutemero de diapositiva 22
  • Nuacutemero de diapositiva 23
  • Nuacutemero de diapositiva 24
  • Nuacutemero de diapositiva 25
  • Eur Respir J 2012 Jun39(6)1458-1467 Epub 2012 Jan 20The European Respiratory Society spirometry tent a unique form of screening for airway obstruction
  • Eur Respir J 2012 Jun39(6)1458-1467 Epub 2012 Jan 20The European Respiratory Society spirometry tent a unique form of screening for airway obstruction
  • Nuacutemero de diapositiva 28
  • Nuacutemero de diapositiva 29
  • 13World COPD Day Activities Are they useful to detect lack of medical care and undertreatment in COPD patients13Immunology and Obstructive Lung Diseases Scientific Section from Argentine Respiratory Medicine Association
  • FarmaEPOC
  • Nuacutemero de diapositiva 32
  • Dejar de fumar agrega antildeos de vida
  • Nuacutemero de diapositiva 34
  • Nuacutemero de diapositiva 35
  • Nuacutemero de diapositiva 36
  • CONCLUSIONES
  • Nuacutemero de diapositiva 38

COPD - PS

COPD ndash Population Screener

IPAG International Primary Care Airways Guidelines

Plan de 3 pasos

Eur Respir J 2012 Jun39(6)1458-1467 Epub 2012 Jan 20

The European Respiratory Society spirometry tent a unique form of screening for airway obstruction

Maio S Sherrill DL Macnee W Lange P Costabel U Dahleacuten SE Sybrecht GW Burghuber OC Stevenson R Toslashnnesen P Haeussinger K Hedlin GBauer TT Riedler J Nicod L Carlsen KH Viegi G on behalf of the European Respiratory SocietyEuropean Lung Foundation Spirometry Tent working group

Abstract

In order to raise public awareness of the importance of early detection of airway obstruction and to enable many people who had not been tested previously to have their lung function measured the European Lung Foundation and the European Respiratory Society (ERS) organised a spirometry testing tent during the annual ERS Congresses in 2004-2009 Spirometry was performed during the ERS Congresses in volunteers all participants answered a simple brief questionnaire on their descriptive characteristics smoking and asthma Portable spirometers were freely provided by the manufacturer Nurses and doctors from pulmonary departments of local hospitalsuniversities gave their service for free Lower limit of normal (LLN) and Global Initiative for Chronic Obstructive Lung Disease (GOLD) criteria for diagnosing and grading airway obstruction were used Of 12448 participants in six congress cities 10395 (835) performed acceptable spirometry (mean age 510plusmn184 yrs 255 smokers 55 asthmatic) Airway obstruction was present in 124 of investigated subjects according to LLN criteria and 203 according to GOLD criteria Through multinomial logistic regression analysis age smoking habits and asthma were significant risk factors for airway obstruction Relative risk ratio and 95 confidence interval for LLN stage I for example was 29 (20-41) for the youngest age (le19 yrs) 19 (12-30) for the oldest age (ge80 yrs) 24 (20-29) for current smokers and 28 (22-36) for reported asthma diagnosis In addition to being a useful advocacy tool the spirometry tent represents an unusual occasion for early detection of airway obstruction in large numbers of city residents with an important public health perspective

Eur Respir J 2012 Jun39(6)1458-1467 Epub 2012 Jan 20

The European Respiratory Society spirometry tent a unique form of screening for airway obstruction

Maio S Sherrill DL Macnee W Lange P Costabel U Dahleacuten SE Sybrecht GW Burghuber OC Stevenson R Toslashnnesen P Haeussinger K Hedlin GBauer TT Riedler J Nicod L Carlsen KH Viegi G on behalf of the European Respiratory SocietyEuropean Lung Foundation Spirometry Tent working group

Abstract

In order to raise public awareness of the importance of early detection of airway obstruction and to enable many people who had not been tested previously to have their lung function measured the European Lung Foundation and the European Respiratory Society (ERS) organised a spirometry testing tent during the annual ERS Congresses in 2004-2009 Spirometry was performed during the ERS Congresses in volunteers all participants answered a simple brief questionnaire on their descriptive characteristics smoking and asthma Portable spirometers were freely provided by the manufacturer Nurses and doctors from pulmonary departments of local hospitalsuniversities gave their service for free Lower limit of normal (LLN) and Global Initiative for Chronic Obstructive Lung Disease (GOLD) criteria for diagnosing and grading airway obstruction were used Of 12448 participants in six congress cities 10395 (835) performed acceptable spirometry (mean age 510plusmn184 yrs 255 smokers 55 asthmatic) Airway obstruction was present in 124 of investigated subjects according to LLN criteria and 203 according to GOLD criteria Through multinomial logistic regression analysis age smoking habits and asthma were significant risk factors for airway obstruction Relative risk ratio and 95 confidence interval for LLN stage I for example was 29 (20-41) for the youngest age (le19 yrs) 19 (12-30) for the oldest age (ge80 yrs) 24 (20-29) for current smokers and 28 (22-36) for reported asthma diagnosis In addition to being a useful advocacy tool the spirometry tent represents an unusual occasion for early detection of airway obstruction in large numbers of city residents with an important public health perspective

Seccioacuten de Inmunologiacutea y Enfermedades Obstructivas

World COPD Day Activities Are they useful to detect lack of medical care and undertreatment in COPD patients

37 CIUDADES 8 CIUDADES

1265 SUJETOS

335

EPOC

World COPD Day Activities Are they useful to detect lack of

medical care and undertreatment in COPD patients Immunology and Obstructive Lung Diseases Scientific Section from Argentine Respiratory Medicine Association

FarmaEPOC

100 farmacias de la provincia de Barcelona realizaraacuten escalonadamente espirometriacuteas ambulatorias a personas con factores de riesgo hasta alcanzar una muestra de 3600 usuarios Las espirometriacuteas seraacuten evaluadas con una aplicacioacuten telemaacutetica que permite no soacutelo garantizar la calidad de las espirometriacuteas realizadas sino mantener una comunicacioacuten on-line entre la farmacia y los laboratorios de funcioacuten pulmonar del Hospital Cliacutenic y el Hospital de Sant Pau FarmaEPOC 2 tiene como objetivo confirmar los datos del estudio piloto FarmaEPOC 1 que concluye la viabilidad de la prueba de la espirometriacutea en la oficina de farmacia De este modo FarmaEPOC 2 da un paso maacutes y surge de la necesidad de conocer tanto las caracteriacutesticas epidemioloacutegicas de los usuarios con alteracioacuten del flujo aeacutereo cribados en farmacias Abandono del tabaco principal estrategia de intervencioacuten precoz

Dejar de fumar agrega antildeos de vida

Aba

ndon

o a

los

45-5

4 antilde

os

Fumadores No fumadores Abandono a los 45-54 antildeos

n=34439 meacutedicos britaacutenicos

Antildeos

de sobrevida

desde edad promedio de 50 antildeos

Abandono en promedio a los 50 antildeos

bull Disminuye la mortalidad (A) bull Disminuye declinacioacuten funcional bull La educacioacuten es central (A)

Doll et al BMJ 2004 328 1519-1527

Seccioacuten de Inmunologiacutea y Enfermedades Obstructivas

2011

External validation to COPD deteccion questionnaire

Bergna M Garcia G Grabre P Alchapar R Larrateguy L Altieri H

Figueroa Casas JC Zabert G Nannini L Pascanky D Fucile S

CuestionariO de Deteccioacuten de EPOC CODE

EDAD gt58 ANtildeOS

gt20 PAQUETESANtildeOS TOS CRONICA

FLEMA CROacuteNICA DISNEA ESFUERZO SEXO MASCULINO

BMIlt22

CON SOLO 3 Sensibilidad de 95 y un VPN del 96

CONCLUSIONES bull Para mejorar los resultados globales de la Epoc

debemos detectarla mas tempranamente

bull Actividades en la comunidad cuestionarios espirometria abreviada son herramientas que colaboran con estos objetivos

bull Detectando y confirmando la Epoc por espirometria nuestros pacientes tendran mas oportunidades

Recomendaciones para el Diagnoacutestico y Tratamiento de la Enfermedad Pulmonar Obstructiva Croacutenica EPOC

Muchas Graciashellip

  • ESTRATEGIAS DE LA DETECCION TEMPRANA DE EPOC
  • Como mejorar nuestro manejo y enfoque sobre EPOC
  • Nuacutemero de diapositiva 3
  • Nuacutemero de diapositiva 4
  • Nuacutemero de diapositiva 5
  • Nuacutemero de diapositiva 6
  • Diferencias en el financiamiento del NIH para enfermedades especiacuteficas en USA
  • Espirometriacutea herramienta clave
  • Espiroacutemetro - Tensioacutemetro
  • Nuacutemero de diapositiva 10
  • Nuacutemero de diapositiva 11
  • COPD - PS
  • COPD ndash Population Screener
  • Nuacutemero de diapositiva 14
  • Nuacutemero de diapositiva 15
  • Nuacutemero de diapositiva 16
  • Nuacutemero de diapositiva 17
  • Nuacutemero de diapositiva 18
  • IPAG International Primary Care Airways Guidelines
  • Plan de 3 pasos
  • Nuacutemero de diapositiva 21
  • Nuacutemero de diapositiva 22
  • Nuacutemero de diapositiva 23
  • Nuacutemero de diapositiva 24
  • Nuacutemero de diapositiva 25
  • Eur Respir J 2012 Jun39(6)1458-1467 Epub 2012 Jan 20The European Respiratory Society spirometry tent a unique form of screening for airway obstruction
  • Eur Respir J 2012 Jun39(6)1458-1467 Epub 2012 Jan 20The European Respiratory Society spirometry tent a unique form of screening for airway obstruction
  • Nuacutemero de diapositiva 28
  • Nuacutemero de diapositiva 29
  • 13World COPD Day Activities Are they useful to detect lack of medical care and undertreatment in COPD patients13Immunology and Obstructive Lung Diseases Scientific Section from Argentine Respiratory Medicine Association
  • FarmaEPOC
  • Nuacutemero de diapositiva 32
  • Dejar de fumar agrega antildeos de vida
  • Nuacutemero de diapositiva 34
  • Nuacutemero de diapositiva 35
  • Nuacutemero de diapositiva 36
  • CONCLUSIONES
  • Nuacutemero de diapositiva 38

COPD ndash Population Screener

IPAG International Primary Care Airways Guidelines

Plan de 3 pasos

Eur Respir J 2012 Jun39(6)1458-1467 Epub 2012 Jan 20

The European Respiratory Society spirometry tent a unique form of screening for airway obstruction

Maio S Sherrill DL Macnee W Lange P Costabel U Dahleacuten SE Sybrecht GW Burghuber OC Stevenson R Toslashnnesen P Haeussinger K Hedlin GBauer TT Riedler J Nicod L Carlsen KH Viegi G on behalf of the European Respiratory SocietyEuropean Lung Foundation Spirometry Tent working group

Abstract

In order to raise public awareness of the importance of early detection of airway obstruction and to enable many people who had not been tested previously to have their lung function measured the European Lung Foundation and the European Respiratory Society (ERS) organised a spirometry testing tent during the annual ERS Congresses in 2004-2009 Spirometry was performed during the ERS Congresses in volunteers all participants answered a simple brief questionnaire on their descriptive characteristics smoking and asthma Portable spirometers were freely provided by the manufacturer Nurses and doctors from pulmonary departments of local hospitalsuniversities gave their service for free Lower limit of normal (LLN) and Global Initiative for Chronic Obstructive Lung Disease (GOLD) criteria for diagnosing and grading airway obstruction were used Of 12448 participants in six congress cities 10395 (835) performed acceptable spirometry (mean age 510plusmn184 yrs 255 smokers 55 asthmatic) Airway obstruction was present in 124 of investigated subjects according to LLN criteria and 203 according to GOLD criteria Through multinomial logistic regression analysis age smoking habits and asthma were significant risk factors for airway obstruction Relative risk ratio and 95 confidence interval for LLN stage I for example was 29 (20-41) for the youngest age (le19 yrs) 19 (12-30) for the oldest age (ge80 yrs) 24 (20-29) for current smokers and 28 (22-36) for reported asthma diagnosis In addition to being a useful advocacy tool the spirometry tent represents an unusual occasion for early detection of airway obstruction in large numbers of city residents with an important public health perspective

Eur Respir J 2012 Jun39(6)1458-1467 Epub 2012 Jan 20

The European Respiratory Society spirometry tent a unique form of screening for airway obstruction

Maio S Sherrill DL Macnee W Lange P Costabel U Dahleacuten SE Sybrecht GW Burghuber OC Stevenson R Toslashnnesen P Haeussinger K Hedlin GBauer TT Riedler J Nicod L Carlsen KH Viegi G on behalf of the European Respiratory SocietyEuropean Lung Foundation Spirometry Tent working group

Abstract

In order to raise public awareness of the importance of early detection of airway obstruction and to enable many people who had not been tested previously to have their lung function measured the European Lung Foundation and the European Respiratory Society (ERS) organised a spirometry testing tent during the annual ERS Congresses in 2004-2009 Spirometry was performed during the ERS Congresses in volunteers all participants answered a simple brief questionnaire on their descriptive characteristics smoking and asthma Portable spirometers were freely provided by the manufacturer Nurses and doctors from pulmonary departments of local hospitalsuniversities gave their service for free Lower limit of normal (LLN) and Global Initiative for Chronic Obstructive Lung Disease (GOLD) criteria for diagnosing and grading airway obstruction were used Of 12448 participants in six congress cities 10395 (835) performed acceptable spirometry (mean age 510plusmn184 yrs 255 smokers 55 asthmatic) Airway obstruction was present in 124 of investigated subjects according to LLN criteria and 203 according to GOLD criteria Through multinomial logistic regression analysis age smoking habits and asthma were significant risk factors for airway obstruction Relative risk ratio and 95 confidence interval for LLN stage I for example was 29 (20-41) for the youngest age (le19 yrs) 19 (12-30) for the oldest age (ge80 yrs) 24 (20-29) for current smokers and 28 (22-36) for reported asthma diagnosis In addition to being a useful advocacy tool the spirometry tent represents an unusual occasion for early detection of airway obstruction in large numbers of city residents with an important public health perspective

Seccioacuten de Inmunologiacutea y Enfermedades Obstructivas

World COPD Day Activities Are they useful to detect lack of medical care and undertreatment in COPD patients

37 CIUDADES 8 CIUDADES

1265 SUJETOS

335

EPOC

World COPD Day Activities Are they useful to detect lack of

medical care and undertreatment in COPD patients Immunology and Obstructive Lung Diseases Scientific Section from Argentine Respiratory Medicine Association

FarmaEPOC

100 farmacias de la provincia de Barcelona realizaraacuten escalonadamente espirometriacuteas ambulatorias a personas con factores de riesgo hasta alcanzar una muestra de 3600 usuarios Las espirometriacuteas seraacuten evaluadas con una aplicacioacuten telemaacutetica que permite no soacutelo garantizar la calidad de las espirometriacuteas realizadas sino mantener una comunicacioacuten on-line entre la farmacia y los laboratorios de funcioacuten pulmonar del Hospital Cliacutenic y el Hospital de Sant Pau FarmaEPOC 2 tiene como objetivo confirmar los datos del estudio piloto FarmaEPOC 1 que concluye la viabilidad de la prueba de la espirometriacutea en la oficina de farmacia De este modo FarmaEPOC 2 da un paso maacutes y surge de la necesidad de conocer tanto las caracteriacutesticas epidemioloacutegicas de los usuarios con alteracioacuten del flujo aeacutereo cribados en farmacias Abandono del tabaco principal estrategia de intervencioacuten precoz

Dejar de fumar agrega antildeos de vida

Aba

ndon

o a

los

45-5

4 antilde

os

Fumadores No fumadores Abandono a los 45-54 antildeos

n=34439 meacutedicos britaacutenicos

Antildeos

de sobrevida

desde edad promedio de 50 antildeos

Abandono en promedio a los 50 antildeos

bull Disminuye la mortalidad (A) bull Disminuye declinacioacuten funcional bull La educacioacuten es central (A)

Doll et al BMJ 2004 328 1519-1527

Seccioacuten de Inmunologiacutea y Enfermedades Obstructivas

2011

External validation to COPD deteccion questionnaire

Bergna M Garcia G Grabre P Alchapar R Larrateguy L Altieri H

Figueroa Casas JC Zabert G Nannini L Pascanky D Fucile S

CuestionariO de Deteccioacuten de EPOC CODE

EDAD gt58 ANtildeOS

gt20 PAQUETESANtildeOS TOS CRONICA

FLEMA CROacuteNICA DISNEA ESFUERZO SEXO MASCULINO

BMIlt22

CON SOLO 3 Sensibilidad de 95 y un VPN del 96

CONCLUSIONES bull Para mejorar los resultados globales de la Epoc

debemos detectarla mas tempranamente

bull Actividades en la comunidad cuestionarios espirometria abreviada son herramientas que colaboran con estos objetivos

bull Detectando y confirmando la Epoc por espirometria nuestros pacientes tendran mas oportunidades

Recomendaciones para el Diagnoacutestico y Tratamiento de la Enfermedad Pulmonar Obstructiva Croacutenica EPOC

Muchas Graciashellip

  • ESTRATEGIAS DE LA DETECCION TEMPRANA DE EPOC
  • Como mejorar nuestro manejo y enfoque sobre EPOC
  • Nuacutemero de diapositiva 3
  • Nuacutemero de diapositiva 4
  • Nuacutemero de diapositiva 5
  • Nuacutemero de diapositiva 6
  • Diferencias en el financiamiento del NIH para enfermedades especiacuteficas en USA
  • Espirometriacutea herramienta clave
  • Espiroacutemetro - Tensioacutemetro
  • Nuacutemero de diapositiva 10
  • Nuacutemero de diapositiva 11
  • COPD - PS
  • COPD ndash Population Screener
  • Nuacutemero de diapositiva 14
  • Nuacutemero de diapositiva 15
  • Nuacutemero de diapositiva 16
  • Nuacutemero de diapositiva 17
  • Nuacutemero de diapositiva 18
  • IPAG International Primary Care Airways Guidelines
  • Plan de 3 pasos
  • Nuacutemero de diapositiva 21
  • Nuacutemero de diapositiva 22
  • Nuacutemero de diapositiva 23
  • Nuacutemero de diapositiva 24
  • Nuacutemero de diapositiva 25
  • Eur Respir J 2012 Jun39(6)1458-1467 Epub 2012 Jan 20The European Respiratory Society spirometry tent a unique form of screening for airway obstruction
  • Eur Respir J 2012 Jun39(6)1458-1467 Epub 2012 Jan 20The European Respiratory Society spirometry tent a unique form of screening for airway obstruction
  • Nuacutemero de diapositiva 28
  • Nuacutemero de diapositiva 29
  • 13World COPD Day Activities Are they useful to detect lack of medical care and undertreatment in COPD patients13Immunology and Obstructive Lung Diseases Scientific Section from Argentine Respiratory Medicine Association
  • FarmaEPOC
  • Nuacutemero de diapositiva 32
  • Dejar de fumar agrega antildeos de vida
  • Nuacutemero de diapositiva 34
  • Nuacutemero de diapositiva 35
  • Nuacutemero de diapositiva 36
  • CONCLUSIONES
  • Nuacutemero de diapositiva 38

IPAG International Primary Care Airways Guidelines

Plan de 3 pasos

Eur Respir J 2012 Jun39(6)1458-1467 Epub 2012 Jan 20

The European Respiratory Society spirometry tent a unique form of screening for airway obstruction

Maio S Sherrill DL Macnee W Lange P Costabel U Dahleacuten SE Sybrecht GW Burghuber OC Stevenson R Toslashnnesen P Haeussinger K Hedlin GBauer TT Riedler J Nicod L Carlsen KH Viegi G on behalf of the European Respiratory SocietyEuropean Lung Foundation Spirometry Tent working group

Abstract

In order to raise public awareness of the importance of early detection of airway obstruction and to enable many people who had not been tested previously to have their lung function measured the European Lung Foundation and the European Respiratory Society (ERS) organised a spirometry testing tent during the annual ERS Congresses in 2004-2009 Spirometry was performed during the ERS Congresses in volunteers all participants answered a simple brief questionnaire on their descriptive characteristics smoking and asthma Portable spirometers were freely provided by the manufacturer Nurses and doctors from pulmonary departments of local hospitalsuniversities gave their service for free Lower limit of normal (LLN) and Global Initiative for Chronic Obstructive Lung Disease (GOLD) criteria for diagnosing and grading airway obstruction were used Of 12448 participants in six congress cities 10395 (835) performed acceptable spirometry (mean age 510plusmn184 yrs 255 smokers 55 asthmatic) Airway obstruction was present in 124 of investigated subjects according to LLN criteria and 203 according to GOLD criteria Through multinomial logistic regression analysis age smoking habits and asthma were significant risk factors for airway obstruction Relative risk ratio and 95 confidence interval for LLN stage I for example was 29 (20-41) for the youngest age (le19 yrs) 19 (12-30) for the oldest age (ge80 yrs) 24 (20-29) for current smokers and 28 (22-36) for reported asthma diagnosis In addition to being a useful advocacy tool the spirometry tent represents an unusual occasion for early detection of airway obstruction in large numbers of city residents with an important public health perspective

Eur Respir J 2012 Jun39(6)1458-1467 Epub 2012 Jan 20

The European Respiratory Society spirometry tent a unique form of screening for airway obstruction

Maio S Sherrill DL Macnee W Lange P Costabel U Dahleacuten SE Sybrecht GW Burghuber OC Stevenson R Toslashnnesen P Haeussinger K Hedlin GBauer TT Riedler J Nicod L Carlsen KH Viegi G on behalf of the European Respiratory SocietyEuropean Lung Foundation Spirometry Tent working group

Abstract

In order to raise public awareness of the importance of early detection of airway obstruction and to enable many people who had not been tested previously to have their lung function measured the European Lung Foundation and the European Respiratory Society (ERS) organised a spirometry testing tent during the annual ERS Congresses in 2004-2009 Spirometry was performed during the ERS Congresses in volunteers all participants answered a simple brief questionnaire on their descriptive characteristics smoking and asthma Portable spirometers were freely provided by the manufacturer Nurses and doctors from pulmonary departments of local hospitalsuniversities gave their service for free Lower limit of normal (LLN) and Global Initiative for Chronic Obstructive Lung Disease (GOLD) criteria for diagnosing and grading airway obstruction were used Of 12448 participants in six congress cities 10395 (835) performed acceptable spirometry (mean age 510plusmn184 yrs 255 smokers 55 asthmatic) Airway obstruction was present in 124 of investigated subjects according to LLN criteria and 203 according to GOLD criteria Through multinomial logistic regression analysis age smoking habits and asthma were significant risk factors for airway obstruction Relative risk ratio and 95 confidence interval for LLN stage I for example was 29 (20-41) for the youngest age (le19 yrs) 19 (12-30) for the oldest age (ge80 yrs) 24 (20-29) for current smokers and 28 (22-36) for reported asthma diagnosis In addition to being a useful advocacy tool the spirometry tent represents an unusual occasion for early detection of airway obstruction in large numbers of city residents with an important public health perspective

Seccioacuten de Inmunologiacutea y Enfermedades Obstructivas

World COPD Day Activities Are they useful to detect lack of medical care and undertreatment in COPD patients

37 CIUDADES 8 CIUDADES

1265 SUJETOS

335

EPOC

World COPD Day Activities Are they useful to detect lack of

medical care and undertreatment in COPD patients Immunology and Obstructive Lung Diseases Scientific Section from Argentine Respiratory Medicine Association

FarmaEPOC

100 farmacias de la provincia de Barcelona realizaraacuten escalonadamente espirometriacuteas ambulatorias a personas con factores de riesgo hasta alcanzar una muestra de 3600 usuarios Las espirometriacuteas seraacuten evaluadas con una aplicacioacuten telemaacutetica que permite no soacutelo garantizar la calidad de las espirometriacuteas realizadas sino mantener una comunicacioacuten on-line entre la farmacia y los laboratorios de funcioacuten pulmonar del Hospital Cliacutenic y el Hospital de Sant Pau FarmaEPOC 2 tiene como objetivo confirmar los datos del estudio piloto FarmaEPOC 1 que concluye la viabilidad de la prueba de la espirometriacutea en la oficina de farmacia De este modo FarmaEPOC 2 da un paso maacutes y surge de la necesidad de conocer tanto las caracteriacutesticas epidemioloacutegicas de los usuarios con alteracioacuten del flujo aeacutereo cribados en farmacias Abandono del tabaco principal estrategia de intervencioacuten precoz

Dejar de fumar agrega antildeos de vida

Aba

ndon

o a

los

45-5

4 antilde

os

Fumadores No fumadores Abandono a los 45-54 antildeos

n=34439 meacutedicos britaacutenicos

Antildeos

de sobrevida

desde edad promedio de 50 antildeos

Abandono en promedio a los 50 antildeos

bull Disminuye la mortalidad (A) bull Disminuye declinacioacuten funcional bull La educacioacuten es central (A)

Doll et al BMJ 2004 328 1519-1527

Seccioacuten de Inmunologiacutea y Enfermedades Obstructivas

2011

External validation to COPD deteccion questionnaire

Bergna M Garcia G Grabre P Alchapar R Larrateguy L Altieri H

Figueroa Casas JC Zabert G Nannini L Pascanky D Fucile S

CuestionariO de Deteccioacuten de EPOC CODE

EDAD gt58 ANtildeOS

gt20 PAQUETESANtildeOS TOS CRONICA

FLEMA CROacuteNICA DISNEA ESFUERZO SEXO MASCULINO

BMIlt22

CON SOLO 3 Sensibilidad de 95 y un VPN del 96

CONCLUSIONES bull Para mejorar los resultados globales de la Epoc

debemos detectarla mas tempranamente

bull Actividades en la comunidad cuestionarios espirometria abreviada son herramientas que colaboran con estos objetivos

bull Detectando y confirmando la Epoc por espirometria nuestros pacientes tendran mas oportunidades

Recomendaciones para el Diagnoacutestico y Tratamiento de la Enfermedad Pulmonar Obstructiva Croacutenica EPOC

Muchas Graciashellip

  • ESTRATEGIAS DE LA DETECCION TEMPRANA DE EPOC
  • Como mejorar nuestro manejo y enfoque sobre EPOC
  • Nuacutemero de diapositiva 3
  • Nuacutemero de diapositiva 4
  • Nuacutemero de diapositiva 5
  • Nuacutemero de diapositiva 6
  • Diferencias en el financiamiento del NIH para enfermedades especiacuteficas en USA
  • Espirometriacutea herramienta clave
  • Espiroacutemetro - Tensioacutemetro
  • Nuacutemero de diapositiva 10
  • Nuacutemero de diapositiva 11
  • COPD - PS
  • COPD ndash Population Screener
  • Nuacutemero de diapositiva 14
  • Nuacutemero de diapositiva 15
  • Nuacutemero de diapositiva 16
  • Nuacutemero de diapositiva 17
  • Nuacutemero de diapositiva 18
  • IPAG International Primary Care Airways Guidelines
  • Plan de 3 pasos
  • Nuacutemero de diapositiva 21
  • Nuacutemero de diapositiva 22
  • Nuacutemero de diapositiva 23
  • Nuacutemero de diapositiva 24
  • Nuacutemero de diapositiva 25
  • Eur Respir J 2012 Jun39(6)1458-1467 Epub 2012 Jan 20The European Respiratory Society spirometry tent a unique form of screening for airway obstruction
  • Eur Respir J 2012 Jun39(6)1458-1467 Epub 2012 Jan 20The European Respiratory Society spirometry tent a unique form of screening for airway obstruction
  • Nuacutemero de diapositiva 28
  • Nuacutemero de diapositiva 29
  • 13World COPD Day Activities Are they useful to detect lack of medical care and undertreatment in COPD patients13Immunology and Obstructive Lung Diseases Scientific Section from Argentine Respiratory Medicine Association
  • FarmaEPOC
  • Nuacutemero de diapositiva 32
  • Dejar de fumar agrega antildeos de vida
  • Nuacutemero de diapositiva 34
  • Nuacutemero de diapositiva 35
  • Nuacutemero de diapositiva 36
  • CONCLUSIONES
  • Nuacutemero de diapositiva 38

Plan de 3 pasos

Eur Respir J 2012 Jun39(6)1458-1467 Epub 2012 Jan 20

The European Respiratory Society spirometry tent a unique form of screening for airway obstruction

Maio S Sherrill DL Macnee W Lange P Costabel U Dahleacuten SE Sybrecht GW Burghuber OC Stevenson R Toslashnnesen P Haeussinger K Hedlin GBauer TT Riedler J Nicod L Carlsen KH Viegi G on behalf of the European Respiratory SocietyEuropean Lung Foundation Spirometry Tent working group

Abstract

In order to raise public awareness of the importance of early detection of airway obstruction and to enable many people who had not been tested previously to have their lung function measured the European Lung Foundation and the European Respiratory Society (ERS) organised a spirometry testing tent during the annual ERS Congresses in 2004-2009 Spirometry was performed during the ERS Congresses in volunteers all participants answered a simple brief questionnaire on their descriptive characteristics smoking and asthma Portable spirometers were freely provided by the manufacturer Nurses and doctors from pulmonary departments of local hospitalsuniversities gave their service for free Lower limit of normal (LLN) and Global Initiative for Chronic Obstructive Lung Disease (GOLD) criteria for diagnosing and grading airway obstruction were used Of 12448 participants in six congress cities 10395 (835) performed acceptable spirometry (mean age 510plusmn184 yrs 255 smokers 55 asthmatic) Airway obstruction was present in 124 of investigated subjects according to LLN criteria and 203 according to GOLD criteria Through multinomial logistic regression analysis age smoking habits and asthma were significant risk factors for airway obstruction Relative risk ratio and 95 confidence interval for LLN stage I for example was 29 (20-41) for the youngest age (le19 yrs) 19 (12-30) for the oldest age (ge80 yrs) 24 (20-29) for current smokers and 28 (22-36) for reported asthma diagnosis In addition to being a useful advocacy tool the spirometry tent represents an unusual occasion for early detection of airway obstruction in large numbers of city residents with an important public health perspective

Eur Respir J 2012 Jun39(6)1458-1467 Epub 2012 Jan 20

The European Respiratory Society spirometry tent a unique form of screening for airway obstruction

Maio S Sherrill DL Macnee W Lange P Costabel U Dahleacuten SE Sybrecht GW Burghuber OC Stevenson R Toslashnnesen P Haeussinger K Hedlin GBauer TT Riedler J Nicod L Carlsen KH Viegi G on behalf of the European Respiratory SocietyEuropean Lung Foundation Spirometry Tent working group

Abstract

In order to raise public awareness of the importance of early detection of airway obstruction and to enable many people who had not been tested previously to have their lung function measured the European Lung Foundation and the European Respiratory Society (ERS) organised a spirometry testing tent during the annual ERS Congresses in 2004-2009 Spirometry was performed during the ERS Congresses in volunteers all participants answered a simple brief questionnaire on their descriptive characteristics smoking and asthma Portable spirometers were freely provided by the manufacturer Nurses and doctors from pulmonary departments of local hospitalsuniversities gave their service for free Lower limit of normal (LLN) and Global Initiative for Chronic Obstructive Lung Disease (GOLD) criteria for diagnosing and grading airway obstruction were used Of 12448 participants in six congress cities 10395 (835) performed acceptable spirometry (mean age 510plusmn184 yrs 255 smokers 55 asthmatic) Airway obstruction was present in 124 of investigated subjects according to LLN criteria and 203 according to GOLD criteria Through multinomial logistic regression analysis age smoking habits and asthma were significant risk factors for airway obstruction Relative risk ratio and 95 confidence interval for LLN stage I for example was 29 (20-41) for the youngest age (le19 yrs) 19 (12-30) for the oldest age (ge80 yrs) 24 (20-29) for current smokers and 28 (22-36) for reported asthma diagnosis In addition to being a useful advocacy tool the spirometry tent represents an unusual occasion for early detection of airway obstruction in large numbers of city residents with an important public health perspective

Seccioacuten de Inmunologiacutea y Enfermedades Obstructivas

World COPD Day Activities Are they useful to detect lack of medical care and undertreatment in COPD patients

37 CIUDADES 8 CIUDADES

1265 SUJETOS

335

EPOC

World COPD Day Activities Are they useful to detect lack of

medical care and undertreatment in COPD patients Immunology and Obstructive Lung Diseases Scientific Section from Argentine Respiratory Medicine Association

FarmaEPOC

100 farmacias de la provincia de Barcelona realizaraacuten escalonadamente espirometriacuteas ambulatorias a personas con factores de riesgo hasta alcanzar una muestra de 3600 usuarios Las espirometriacuteas seraacuten evaluadas con una aplicacioacuten telemaacutetica que permite no soacutelo garantizar la calidad de las espirometriacuteas realizadas sino mantener una comunicacioacuten on-line entre la farmacia y los laboratorios de funcioacuten pulmonar del Hospital Cliacutenic y el Hospital de Sant Pau FarmaEPOC 2 tiene como objetivo confirmar los datos del estudio piloto FarmaEPOC 1 que concluye la viabilidad de la prueba de la espirometriacutea en la oficina de farmacia De este modo FarmaEPOC 2 da un paso maacutes y surge de la necesidad de conocer tanto las caracteriacutesticas epidemioloacutegicas de los usuarios con alteracioacuten del flujo aeacutereo cribados en farmacias Abandono del tabaco principal estrategia de intervencioacuten precoz

Dejar de fumar agrega antildeos de vida

Aba

ndon

o a

los

45-5

4 antilde

os

Fumadores No fumadores Abandono a los 45-54 antildeos

n=34439 meacutedicos britaacutenicos

Antildeos

de sobrevida

desde edad promedio de 50 antildeos

Abandono en promedio a los 50 antildeos

bull Disminuye la mortalidad (A) bull Disminuye declinacioacuten funcional bull La educacioacuten es central (A)

Doll et al BMJ 2004 328 1519-1527

Seccioacuten de Inmunologiacutea y Enfermedades Obstructivas

2011

External validation to COPD deteccion questionnaire

Bergna M Garcia G Grabre P Alchapar R Larrateguy L Altieri H

Figueroa Casas JC Zabert G Nannini L Pascanky D Fucile S

CuestionariO de Deteccioacuten de EPOC CODE

EDAD gt58 ANtildeOS

gt20 PAQUETESANtildeOS TOS CRONICA

FLEMA CROacuteNICA DISNEA ESFUERZO SEXO MASCULINO

BMIlt22

CON SOLO 3 Sensibilidad de 95 y un VPN del 96

CONCLUSIONES bull Para mejorar los resultados globales de la Epoc

debemos detectarla mas tempranamente

bull Actividades en la comunidad cuestionarios espirometria abreviada son herramientas que colaboran con estos objetivos

bull Detectando y confirmando la Epoc por espirometria nuestros pacientes tendran mas oportunidades

Recomendaciones para el Diagnoacutestico y Tratamiento de la Enfermedad Pulmonar Obstructiva Croacutenica EPOC

Muchas Graciashellip

  • ESTRATEGIAS DE LA DETECCION TEMPRANA DE EPOC
  • Como mejorar nuestro manejo y enfoque sobre EPOC
  • Nuacutemero de diapositiva 3
  • Nuacutemero de diapositiva 4
  • Nuacutemero de diapositiva 5
  • Nuacutemero de diapositiva 6
  • Diferencias en el financiamiento del NIH para enfermedades especiacuteficas en USA
  • Espirometriacutea herramienta clave
  • Espiroacutemetro - Tensioacutemetro
  • Nuacutemero de diapositiva 10
  • Nuacutemero de diapositiva 11
  • COPD - PS
  • COPD ndash Population Screener
  • Nuacutemero de diapositiva 14
  • Nuacutemero de diapositiva 15
  • Nuacutemero de diapositiva 16
  • Nuacutemero de diapositiva 17
  • Nuacutemero de diapositiva 18
  • IPAG International Primary Care Airways Guidelines
  • Plan de 3 pasos
  • Nuacutemero de diapositiva 21
  • Nuacutemero de diapositiva 22
  • Nuacutemero de diapositiva 23
  • Nuacutemero de diapositiva 24
  • Nuacutemero de diapositiva 25
  • Eur Respir J 2012 Jun39(6)1458-1467 Epub 2012 Jan 20The European Respiratory Society spirometry tent a unique form of screening for airway obstruction
  • Eur Respir J 2012 Jun39(6)1458-1467 Epub 2012 Jan 20The European Respiratory Society spirometry tent a unique form of screening for airway obstruction
  • Nuacutemero de diapositiva 28
  • Nuacutemero de diapositiva 29
  • 13World COPD Day Activities Are they useful to detect lack of medical care and undertreatment in COPD patients13Immunology and Obstructive Lung Diseases Scientific Section from Argentine Respiratory Medicine Association
  • FarmaEPOC
  • Nuacutemero de diapositiva 32
  • Dejar de fumar agrega antildeos de vida
  • Nuacutemero de diapositiva 34
  • Nuacutemero de diapositiva 35
  • Nuacutemero de diapositiva 36
  • CONCLUSIONES
  • Nuacutemero de diapositiva 38

Eur Respir J 2012 Jun39(6)1458-1467 Epub 2012 Jan 20

The European Respiratory Society spirometry tent a unique form of screening for airway obstruction

Maio S Sherrill DL Macnee W Lange P Costabel U Dahleacuten SE Sybrecht GW Burghuber OC Stevenson R Toslashnnesen P Haeussinger K Hedlin GBauer TT Riedler J Nicod L Carlsen KH Viegi G on behalf of the European Respiratory SocietyEuropean Lung Foundation Spirometry Tent working group

Abstract

In order to raise public awareness of the importance of early detection of airway obstruction and to enable many people who had not been tested previously to have their lung function measured the European Lung Foundation and the European Respiratory Society (ERS) organised a spirometry testing tent during the annual ERS Congresses in 2004-2009 Spirometry was performed during the ERS Congresses in volunteers all participants answered a simple brief questionnaire on their descriptive characteristics smoking and asthma Portable spirometers were freely provided by the manufacturer Nurses and doctors from pulmonary departments of local hospitalsuniversities gave their service for free Lower limit of normal (LLN) and Global Initiative for Chronic Obstructive Lung Disease (GOLD) criteria for diagnosing and grading airway obstruction were used Of 12448 participants in six congress cities 10395 (835) performed acceptable spirometry (mean age 510plusmn184 yrs 255 smokers 55 asthmatic) Airway obstruction was present in 124 of investigated subjects according to LLN criteria and 203 according to GOLD criteria Through multinomial logistic regression analysis age smoking habits and asthma were significant risk factors for airway obstruction Relative risk ratio and 95 confidence interval for LLN stage I for example was 29 (20-41) for the youngest age (le19 yrs) 19 (12-30) for the oldest age (ge80 yrs) 24 (20-29) for current smokers and 28 (22-36) for reported asthma diagnosis In addition to being a useful advocacy tool the spirometry tent represents an unusual occasion for early detection of airway obstruction in large numbers of city residents with an important public health perspective

Eur Respir J 2012 Jun39(6)1458-1467 Epub 2012 Jan 20

The European Respiratory Society spirometry tent a unique form of screening for airway obstruction

Maio S Sherrill DL Macnee W Lange P Costabel U Dahleacuten SE Sybrecht GW Burghuber OC Stevenson R Toslashnnesen P Haeussinger K Hedlin GBauer TT Riedler J Nicod L Carlsen KH Viegi G on behalf of the European Respiratory SocietyEuropean Lung Foundation Spirometry Tent working group

Abstract

In order to raise public awareness of the importance of early detection of airway obstruction and to enable many people who had not been tested previously to have their lung function measured the European Lung Foundation and the European Respiratory Society (ERS) organised a spirometry testing tent during the annual ERS Congresses in 2004-2009 Spirometry was performed during the ERS Congresses in volunteers all participants answered a simple brief questionnaire on their descriptive characteristics smoking and asthma Portable spirometers were freely provided by the manufacturer Nurses and doctors from pulmonary departments of local hospitalsuniversities gave their service for free Lower limit of normal (LLN) and Global Initiative for Chronic Obstructive Lung Disease (GOLD) criteria for diagnosing and grading airway obstruction were used Of 12448 participants in six congress cities 10395 (835) performed acceptable spirometry (mean age 510plusmn184 yrs 255 smokers 55 asthmatic) Airway obstruction was present in 124 of investigated subjects according to LLN criteria and 203 according to GOLD criteria Through multinomial logistic regression analysis age smoking habits and asthma were significant risk factors for airway obstruction Relative risk ratio and 95 confidence interval for LLN stage I for example was 29 (20-41) for the youngest age (le19 yrs) 19 (12-30) for the oldest age (ge80 yrs) 24 (20-29) for current smokers and 28 (22-36) for reported asthma diagnosis In addition to being a useful advocacy tool the spirometry tent represents an unusual occasion for early detection of airway obstruction in large numbers of city residents with an important public health perspective

Seccioacuten de Inmunologiacutea y Enfermedades Obstructivas

World COPD Day Activities Are they useful to detect lack of medical care and undertreatment in COPD patients

37 CIUDADES 8 CIUDADES

1265 SUJETOS

335

EPOC

World COPD Day Activities Are they useful to detect lack of

medical care and undertreatment in COPD patients Immunology and Obstructive Lung Diseases Scientific Section from Argentine Respiratory Medicine Association

FarmaEPOC

100 farmacias de la provincia de Barcelona realizaraacuten escalonadamente espirometriacuteas ambulatorias a personas con factores de riesgo hasta alcanzar una muestra de 3600 usuarios Las espirometriacuteas seraacuten evaluadas con una aplicacioacuten telemaacutetica que permite no soacutelo garantizar la calidad de las espirometriacuteas realizadas sino mantener una comunicacioacuten on-line entre la farmacia y los laboratorios de funcioacuten pulmonar del Hospital Cliacutenic y el Hospital de Sant Pau FarmaEPOC 2 tiene como objetivo confirmar los datos del estudio piloto FarmaEPOC 1 que concluye la viabilidad de la prueba de la espirometriacutea en la oficina de farmacia De este modo FarmaEPOC 2 da un paso maacutes y surge de la necesidad de conocer tanto las caracteriacutesticas epidemioloacutegicas de los usuarios con alteracioacuten del flujo aeacutereo cribados en farmacias Abandono del tabaco principal estrategia de intervencioacuten precoz

Dejar de fumar agrega antildeos de vida

Aba

ndon

o a

los

45-5

4 antilde

os

Fumadores No fumadores Abandono a los 45-54 antildeos

n=34439 meacutedicos britaacutenicos

Antildeos

de sobrevida

desde edad promedio de 50 antildeos

Abandono en promedio a los 50 antildeos

bull Disminuye la mortalidad (A) bull Disminuye declinacioacuten funcional bull La educacioacuten es central (A)

Doll et al BMJ 2004 328 1519-1527

Seccioacuten de Inmunologiacutea y Enfermedades Obstructivas

2011

External validation to COPD deteccion questionnaire

Bergna M Garcia G Grabre P Alchapar R Larrateguy L Altieri H

Figueroa Casas JC Zabert G Nannini L Pascanky D Fucile S

CuestionariO de Deteccioacuten de EPOC CODE

EDAD gt58 ANtildeOS

gt20 PAQUETESANtildeOS TOS CRONICA

FLEMA CROacuteNICA DISNEA ESFUERZO SEXO MASCULINO

BMIlt22

CON SOLO 3 Sensibilidad de 95 y un VPN del 96

CONCLUSIONES bull Para mejorar los resultados globales de la Epoc

debemos detectarla mas tempranamente

bull Actividades en la comunidad cuestionarios espirometria abreviada son herramientas que colaboran con estos objetivos

bull Detectando y confirmando la Epoc por espirometria nuestros pacientes tendran mas oportunidades

Recomendaciones para el Diagnoacutestico y Tratamiento de la Enfermedad Pulmonar Obstructiva Croacutenica EPOC

Muchas Graciashellip

  • ESTRATEGIAS DE LA DETECCION TEMPRANA DE EPOC
  • Como mejorar nuestro manejo y enfoque sobre EPOC
  • Nuacutemero de diapositiva 3
  • Nuacutemero de diapositiva 4
  • Nuacutemero de diapositiva 5
  • Nuacutemero de diapositiva 6
  • Diferencias en el financiamiento del NIH para enfermedades especiacuteficas en USA
  • Espirometriacutea herramienta clave
  • Espiroacutemetro - Tensioacutemetro
  • Nuacutemero de diapositiva 10
  • Nuacutemero de diapositiva 11
  • COPD - PS
  • COPD ndash Population Screener
  • Nuacutemero de diapositiva 14
  • Nuacutemero de diapositiva 15
  • Nuacutemero de diapositiva 16
  • Nuacutemero de diapositiva 17
  • Nuacutemero de diapositiva 18
  • IPAG International Primary Care Airways Guidelines
  • Plan de 3 pasos
  • Nuacutemero de diapositiva 21
  • Nuacutemero de diapositiva 22
  • Nuacutemero de diapositiva 23
  • Nuacutemero de diapositiva 24
  • Nuacutemero de diapositiva 25
  • Eur Respir J 2012 Jun39(6)1458-1467 Epub 2012 Jan 20The European Respiratory Society spirometry tent a unique form of screening for airway obstruction
  • Eur Respir J 2012 Jun39(6)1458-1467 Epub 2012 Jan 20The European Respiratory Society spirometry tent a unique form of screening for airway obstruction
  • Nuacutemero de diapositiva 28
  • Nuacutemero de diapositiva 29
  • 13World COPD Day Activities Are they useful to detect lack of medical care and undertreatment in COPD patients13Immunology and Obstructive Lung Diseases Scientific Section from Argentine Respiratory Medicine Association
  • FarmaEPOC
  • Nuacutemero de diapositiva 32
  • Dejar de fumar agrega antildeos de vida
  • Nuacutemero de diapositiva 34
  • Nuacutemero de diapositiva 35
  • Nuacutemero de diapositiva 36
  • CONCLUSIONES
  • Nuacutemero de diapositiva 38

Eur Respir J 2012 Jun39(6)1458-1467 Epub 2012 Jan 20

The European Respiratory Society spirometry tent a unique form of screening for airway obstruction

Maio S Sherrill DL Macnee W Lange P Costabel U Dahleacuten SE Sybrecht GW Burghuber OC Stevenson R Toslashnnesen P Haeussinger K Hedlin GBauer TT Riedler J Nicod L Carlsen KH Viegi G on behalf of the European Respiratory SocietyEuropean Lung Foundation Spirometry Tent working group

Abstract

In order to raise public awareness of the importance of early detection of airway obstruction and to enable many people who had not been tested previously to have their lung function measured the European Lung Foundation and the European Respiratory Society (ERS) organised a spirometry testing tent during the annual ERS Congresses in 2004-2009 Spirometry was performed during the ERS Congresses in volunteers all participants answered a simple brief questionnaire on their descriptive characteristics smoking and asthma Portable spirometers were freely provided by the manufacturer Nurses and doctors from pulmonary departments of local hospitalsuniversities gave their service for free Lower limit of normal (LLN) and Global Initiative for Chronic Obstructive Lung Disease (GOLD) criteria for diagnosing and grading airway obstruction were used Of 12448 participants in six congress cities 10395 (835) performed acceptable spirometry (mean age 510plusmn184 yrs 255 smokers 55 asthmatic) Airway obstruction was present in 124 of investigated subjects according to LLN criteria and 203 according to GOLD criteria Through multinomial logistic regression analysis age smoking habits and asthma were significant risk factors for airway obstruction Relative risk ratio and 95 confidence interval for LLN stage I for example was 29 (20-41) for the youngest age (le19 yrs) 19 (12-30) for the oldest age (ge80 yrs) 24 (20-29) for current smokers and 28 (22-36) for reported asthma diagnosis In addition to being a useful advocacy tool the spirometry tent represents an unusual occasion for early detection of airway obstruction in large numbers of city residents with an important public health perspective

Seccioacuten de Inmunologiacutea y Enfermedades Obstructivas

World COPD Day Activities Are they useful to detect lack of medical care and undertreatment in COPD patients

37 CIUDADES 8 CIUDADES

1265 SUJETOS

335

EPOC

World COPD Day Activities Are they useful to detect lack of

medical care and undertreatment in COPD patients Immunology and Obstructive Lung Diseases Scientific Section from Argentine Respiratory Medicine Association

FarmaEPOC

100 farmacias de la provincia de Barcelona realizaraacuten escalonadamente espirometriacuteas ambulatorias a personas con factores de riesgo hasta alcanzar una muestra de 3600 usuarios Las espirometriacuteas seraacuten evaluadas con una aplicacioacuten telemaacutetica que permite no soacutelo garantizar la calidad de las espirometriacuteas realizadas sino mantener una comunicacioacuten on-line entre la farmacia y los laboratorios de funcioacuten pulmonar del Hospital Cliacutenic y el Hospital de Sant Pau FarmaEPOC 2 tiene como objetivo confirmar los datos del estudio piloto FarmaEPOC 1 que concluye la viabilidad de la prueba de la espirometriacutea en la oficina de farmacia De este modo FarmaEPOC 2 da un paso maacutes y surge de la necesidad de conocer tanto las caracteriacutesticas epidemioloacutegicas de los usuarios con alteracioacuten del flujo aeacutereo cribados en farmacias Abandono del tabaco principal estrategia de intervencioacuten precoz

Dejar de fumar agrega antildeos de vida

Aba

ndon

o a

los

45-5

4 antilde

os

Fumadores No fumadores Abandono a los 45-54 antildeos

n=34439 meacutedicos britaacutenicos

Antildeos

de sobrevida

desde edad promedio de 50 antildeos

Abandono en promedio a los 50 antildeos

bull Disminuye la mortalidad (A) bull Disminuye declinacioacuten funcional bull La educacioacuten es central (A)

Doll et al BMJ 2004 328 1519-1527

Seccioacuten de Inmunologiacutea y Enfermedades Obstructivas

2011

External validation to COPD deteccion questionnaire

Bergna M Garcia G Grabre P Alchapar R Larrateguy L Altieri H

Figueroa Casas JC Zabert G Nannini L Pascanky D Fucile S

CuestionariO de Deteccioacuten de EPOC CODE

EDAD gt58 ANtildeOS

gt20 PAQUETESANtildeOS TOS CRONICA

FLEMA CROacuteNICA DISNEA ESFUERZO SEXO MASCULINO

BMIlt22

CON SOLO 3 Sensibilidad de 95 y un VPN del 96

CONCLUSIONES bull Para mejorar los resultados globales de la Epoc

debemos detectarla mas tempranamente

bull Actividades en la comunidad cuestionarios espirometria abreviada son herramientas que colaboran con estos objetivos

bull Detectando y confirmando la Epoc por espirometria nuestros pacientes tendran mas oportunidades

Recomendaciones para el Diagnoacutestico y Tratamiento de la Enfermedad Pulmonar Obstructiva Croacutenica EPOC

Muchas Graciashellip

  • ESTRATEGIAS DE LA DETECCION TEMPRANA DE EPOC
  • Como mejorar nuestro manejo y enfoque sobre EPOC
  • Nuacutemero de diapositiva 3
  • Nuacutemero de diapositiva 4
  • Nuacutemero de diapositiva 5
  • Nuacutemero de diapositiva 6
  • Diferencias en el financiamiento del NIH para enfermedades especiacuteficas en USA
  • Espirometriacutea herramienta clave
  • Espiroacutemetro - Tensioacutemetro
  • Nuacutemero de diapositiva 10
  • Nuacutemero de diapositiva 11
  • COPD - PS
  • COPD ndash Population Screener
  • Nuacutemero de diapositiva 14
  • Nuacutemero de diapositiva 15
  • Nuacutemero de diapositiva 16
  • Nuacutemero de diapositiva 17
  • Nuacutemero de diapositiva 18
  • IPAG International Primary Care Airways Guidelines
  • Plan de 3 pasos
  • Nuacutemero de diapositiva 21
  • Nuacutemero de diapositiva 22
  • Nuacutemero de diapositiva 23
  • Nuacutemero de diapositiva 24
  • Nuacutemero de diapositiva 25
  • Eur Respir J 2012 Jun39(6)1458-1467 Epub 2012 Jan 20The European Respiratory Society spirometry tent a unique form of screening for airway obstruction
  • Eur Respir J 2012 Jun39(6)1458-1467 Epub 2012 Jan 20The European Respiratory Society spirometry tent a unique form of screening for airway obstruction
  • Nuacutemero de diapositiva 28
  • Nuacutemero de diapositiva 29
  • 13World COPD Day Activities Are they useful to detect lack of medical care and undertreatment in COPD patients13Immunology and Obstructive Lung Diseases Scientific Section from Argentine Respiratory Medicine Association
  • FarmaEPOC
  • Nuacutemero de diapositiva 32
  • Dejar de fumar agrega antildeos de vida
  • Nuacutemero de diapositiva 34
  • Nuacutemero de diapositiva 35
  • Nuacutemero de diapositiva 36
  • CONCLUSIONES
  • Nuacutemero de diapositiva 38

Seccioacuten de Inmunologiacutea y Enfermedades Obstructivas

World COPD Day Activities Are they useful to detect lack of medical care and undertreatment in COPD patients

37 CIUDADES 8 CIUDADES

1265 SUJETOS

335

EPOC

World COPD Day Activities Are they useful to detect lack of

medical care and undertreatment in COPD patients Immunology and Obstructive Lung Diseases Scientific Section from Argentine Respiratory Medicine Association

FarmaEPOC

100 farmacias de la provincia de Barcelona realizaraacuten escalonadamente espirometriacuteas ambulatorias a personas con factores de riesgo hasta alcanzar una muestra de 3600 usuarios Las espirometriacuteas seraacuten evaluadas con una aplicacioacuten telemaacutetica que permite no soacutelo garantizar la calidad de las espirometriacuteas realizadas sino mantener una comunicacioacuten on-line entre la farmacia y los laboratorios de funcioacuten pulmonar del Hospital Cliacutenic y el Hospital de Sant Pau FarmaEPOC 2 tiene como objetivo confirmar los datos del estudio piloto FarmaEPOC 1 que concluye la viabilidad de la prueba de la espirometriacutea en la oficina de farmacia De este modo FarmaEPOC 2 da un paso maacutes y surge de la necesidad de conocer tanto las caracteriacutesticas epidemioloacutegicas de los usuarios con alteracioacuten del flujo aeacutereo cribados en farmacias Abandono del tabaco principal estrategia de intervencioacuten precoz

Dejar de fumar agrega antildeos de vida

Aba

ndon

o a

los

45-5

4 antilde

os

Fumadores No fumadores Abandono a los 45-54 antildeos

n=34439 meacutedicos britaacutenicos

Antildeos

de sobrevida

desde edad promedio de 50 antildeos

Abandono en promedio a los 50 antildeos

bull Disminuye la mortalidad (A) bull Disminuye declinacioacuten funcional bull La educacioacuten es central (A)

Doll et al BMJ 2004 328 1519-1527

Seccioacuten de Inmunologiacutea y Enfermedades Obstructivas

2011

External validation to COPD deteccion questionnaire

Bergna M Garcia G Grabre P Alchapar R Larrateguy L Altieri H

Figueroa Casas JC Zabert G Nannini L Pascanky D Fucile S

CuestionariO de Deteccioacuten de EPOC CODE

EDAD gt58 ANtildeOS

gt20 PAQUETESANtildeOS TOS CRONICA

FLEMA CROacuteNICA DISNEA ESFUERZO SEXO MASCULINO

BMIlt22

CON SOLO 3 Sensibilidad de 95 y un VPN del 96

CONCLUSIONES bull Para mejorar los resultados globales de la Epoc

debemos detectarla mas tempranamente

bull Actividades en la comunidad cuestionarios espirometria abreviada son herramientas que colaboran con estos objetivos

bull Detectando y confirmando la Epoc por espirometria nuestros pacientes tendran mas oportunidades

Recomendaciones para el Diagnoacutestico y Tratamiento de la Enfermedad Pulmonar Obstructiva Croacutenica EPOC

Muchas Graciashellip

  • ESTRATEGIAS DE LA DETECCION TEMPRANA DE EPOC
  • Como mejorar nuestro manejo y enfoque sobre EPOC
  • Nuacutemero de diapositiva 3
  • Nuacutemero de diapositiva 4
  • Nuacutemero de diapositiva 5
  • Nuacutemero de diapositiva 6
  • Diferencias en el financiamiento del NIH para enfermedades especiacuteficas en USA
  • Espirometriacutea herramienta clave
  • Espiroacutemetro - Tensioacutemetro
  • Nuacutemero de diapositiva 10
  • Nuacutemero de diapositiva 11
  • COPD - PS
  • COPD ndash Population Screener
  • Nuacutemero de diapositiva 14
  • Nuacutemero de diapositiva 15
  • Nuacutemero de diapositiva 16
  • Nuacutemero de diapositiva 17
  • Nuacutemero de diapositiva 18
  • IPAG International Primary Care Airways Guidelines
  • Plan de 3 pasos
  • Nuacutemero de diapositiva 21
  • Nuacutemero de diapositiva 22
  • Nuacutemero de diapositiva 23
  • Nuacutemero de diapositiva 24
  • Nuacutemero de diapositiva 25
  • Eur Respir J 2012 Jun39(6)1458-1467 Epub 2012 Jan 20The European Respiratory Society spirometry tent a unique form of screening for airway obstruction
  • Eur Respir J 2012 Jun39(6)1458-1467 Epub 2012 Jan 20The European Respiratory Society spirometry tent a unique form of screening for airway obstruction
  • Nuacutemero de diapositiva 28
  • Nuacutemero de diapositiva 29
  • 13World COPD Day Activities Are they useful to detect lack of medical care and undertreatment in COPD patients13Immunology and Obstructive Lung Diseases Scientific Section from Argentine Respiratory Medicine Association
  • FarmaEPOC
  • Nuacutemero de diapositiva 32
  • Dejar de fumar agrega antildeos de vida
  • Nuacutemero de diapositiva 34
  • Nuacutemero de diapositiva 35
  • Nuacutemero de diapositiva 36
  • CONCLUSIONES
  • Nuacutemero de diapositiva 38

37 CIUDADES 8 CIUDADES

1265 SUJETOS

335

EPOC

World COPD Day Activities Are they useful to detect lack of

medical care and undertreatment in COPD patients Immunology and Obstructive Lung Diseases Scientific Section from Argentine Respiratory Medicine Association

FarmaEPOC

100 farmacias de la provincia de Barcelona realizaraacuten escalonadamente espirometriacuteas ambulatorias a personas con factores de riesgo hasta alcanzar una muestra de 3600 usuarios Las espirometriacuteas seraacuten evaluadas con una aplicacioacuten telemaacutetica que permite no soacutelo garantizar la calidad de las espirometriacuteas realizadas sino mantener una comunicacioacuten on-line entre la farmacia y los laboratorios de funcioacuten pulmonar del Hospital Cliacutenic y el Hospital de Sant Pau FarmaEPOC 2 tiene como objetivo confirmar los datos del estudio piloto FarmaEPOC 1 que concluye la viabilidad de la prueba de la espirometriacutea en la oficina de farmacia De este modo FarmaEPOC 2 da un paso maacutes y surge de la necesidad de conocer tanto las caracteriacutesticas epidemioloacutegicas de los usuarios con alteracioacuten del flujo aeacutereo cribados en farmacias Abandono del tabaco principal estrategia de intervencioacuten precoz

Dejar de fumar agrega antildeos de vida

Aba

ndon

o a

los

45-5

4 antilde

os

Fumadores No fumadores Abandono a los 45-54 antildeos

n=34439 meacutedicos britaacutenicos

Antildeos

de sobrevida

desde edad promedio de 50 antildeos

Abandono en promedio a los 50 antildeos

bull Disminuye la mortalidad (A) bull Disminuye declinacioacuten funcional bull La educacioacuten es central (A)

Doll et al BMJ 2004 328 1519-1527

Seccioacuten de Inmunologiacutea y Enfermedades Obstructivas

2011

External validation to COPD deteccion questionnaire

Bergna M Garcia G Grabre P Alchapar R Larrateguy L Altieri H

Figueroa Casas JC Zabert G Nannini L Pascanky D Fucile S

CuestionariO de Deteccioacuten de EPOC CODE

EDAD gt58 ANtildeOS

gt20 PAQUETESANtildeOS TOS CRONICA

FLEMA CROacuteNICA DISNEA ESFUERZO SEXO MASCULINO

BMIlt22

CON SOLO 3 Sensibilidad de 95 y un VPN del 96

CONCLUSIONES bull Para mejorar los resultados globales de la Epoc

debemos detectarla mas tempranamente

bull Actividades en la comunidad cuestionarios espirometria abreviada son herramientas que colaboran con estos objetivos

bull Detectando y confirmando la Epoc por espirometria nuestros pacientes tendran mas oportunidades

Recomendaciones para el Diagnoacutestico y Tratamiento de la Enfermedad Pulmonar Obstructiva Croacutenica EPOC

Muchas Graciashellip

  • ESTRATEGIAS DE LA DETECCION TEMPRANA DE EPOC
  • Como mejorar nuestro manejo y enfoque sobre EPOC
  • Nuacutemero de diapositiva 3
  • Nuacutemero de diapositiva 4
  • Nuacutemero de diapositiva 5
  • Nuacutemero de diapositiva 6
  • Diferencias en el financiamiento del NIH para enfermedades especiacuteficas en USA
  • Espirometriacutea herramienta clave
  • Espiroacutemetro - Tensioacutemetro
  • Nuacutemero de diapositiva 10
  • Nuacutemero de diapositiva 11
  • COPD - PS
  • COPD ndash Population Screener
  • Nuacutemero de diapositiva 14
  • Nuacutemero de diapositiva 15
  • Nuacutemero de diapositiva 16
  • Nuacutemero de diapositiva 17
  • Nuacutemero de diapositiva 18
  • IPAG International Primary Care Airways Guidelines
  • Plan de 3 pasos
  • Nuacutemero de diapositiva 21
  • Nuacutemero de diapositiva 22
  • Nuacutemero de diapositiva 23
  • Nuacutemero de diapositiva 24
  • Nuacutemero de diapositiva 25
  • Eur Respir J 2012 Jun39(6)1458-1467 Epub 2012 Jan 20The European Respiratory Society spirometry tent a unique form of screening for airway obstruction
  • Eur Respir J 2012 Jun39(6)1458-1467 Epub 2012 Jan 20The European Respiratory Society spirometry tent a unique form of screening for airway obstruction
  • Nuacutemero de diapositiva 28
  • Nuacutemero de diapositiva 29
  • 13World COPD Day Activities Are they useful to detect lack of medical care and undertreatment in COPD patients13Immunology and Obstructive Lung Diseases Scientific Section from Argentine Respiratory Medicine Association
  • FarmaEPOC
  • Nuacutemero de diapositiva 32
  • Dejar de fumar agrega antildeos de vida
  • Nuacutemero de diapositiva 34
  • Nuacutemero de diapositiva 35
  • Nuacutemero de diapositiva 36
  • CONCLUSIONES
  • Nuacutemero de diapositiva 38

World COPD Day Activities Are they useful to detect lack of

medical care and undertreatment in COPD patients Immunology and Obstructive Lung Diseases Scientific Section from Argentine Respiratory Medicine Association

FarmaEPOC

100 farmacias de la provincia de Barcelona realizaraacuten escalonadamente espirometriacuteas ambulatorias a personas con factores de riesgo hasta alcanzar una muestra de 3600 usuarios Las espirometriacuteas seraacuten evaluadas con una aplicacioacuten telemaacutetica que permite no soacutelo garantizar la calidad de las espirometriacuteas realizadas sino mantener una comunicacioacuten on-line entre la farmacia y los laboratorios de funcioacuten pulmonar del Hospital Cliacutenic y el Hospital de Sant Pau FarmaEPOC 2 tiene como objetivo confirmar los datos del estudio piloto FarmaEPOC 1 que concluye la viabilidad de la prueba de la espirometriacutea en la oficina de farmacia De este modo FarmaEPOC 2 da un paso maacutes y surge de la necesidad de conocer tanto las caracteriacutesticas epidemioloacutegicas de los usuarios con alteracioacuten del flujo aeacutereo cribados en farmacias Abandono del tabaco principal estrategia de intervencioacuten precoz

Dejar de fumar agrega antildeos de vida

Aba

ndon

o a

los

45-5

4 antilde

os

Fumadores No fumadores Abandono a los 45-54 antildeos

n=34439 meacutedicos britaacutenicos

Antildeos

de sobrevida

desde edad promedio de 50 antildeos

Abandono en promedio a los 50 antildeos

bull Disminuye la mortalidad (A) bull Disminuye declinacioacuten funcional bull La educacioacuten es central (A)

Doll et al BMJ 2004 328 1519-1527

Seccioacuten de Inmunologiacutea y Enfermedades Obstructivas

2011

External validation to COPD deteccion questionnaire

Bergna M Garcia G Grabre P Alchapar R Larrateguy L Altieri H

Figueroa Casas JC Zabert G Nannini L Pascanky D Fucile S

CuestionariO de Deteccioacuten de EPOC CODE

EDAD gt58 ANtildeOS

gt20 PAQUETESANtildeOS TOS CRONICA

FLEMA CROacuteNICA DISNEA ESFUERZO SEXO MASCULINO

BMIlt22

CON SOLO 3 Sensibilidad de 95 y un VPN del 96

CONCLUSIONES bull Para mejorar los resultados globales de la Epoc

debemos detectarla mas tempranamente

bull Actividades en la comunidad cuestionarios espirometria abreviada son herramientas que colaboran con estos objetivos

bull Detectando y confirmando la Epoc por espirometria nuestros pacientes tendran mas oportunidades

Recomendaciones para el Diagnoacutestico y Tratamiento de la Enfermedad Pulmonar Obstructiva Croacutenica EPOC

Muchas Graciashellip

  • ESTRATEGIAS DE LA DETECCION TEMPRANA DE EPOC
  • Como mejorar nuestro manejo y enfoque sobre EPOC
  • Nuacutemero de diapositiva 3
  • Nuacutemero de diapositiva 4
  • Nuacutemero de diapositiva 5
  • Nuacutemero de diapositiva 6
  • Diferencias en el financiamiento del NIH para enfermedades especiacuteficas en USA
  • Espirometriacutea herramienta clave
  • Espiroacutemetro - Tensioacutemetro
  • Nuacutemero de diapositiva 10
  • Nuacutemero de diapositiva 11
  • COPD - PS
  • COPD ndash Population Screener
  • Nuacutemero de diapositiva 14
  • Nuacutemero de diapositiva 15
  • Nuacutemero de diapositiva 16
  • Nuacutemero de diapositiva 17
  • Nuacutemero de diapositiva 18
  • IPAG International Primary Care Airways Guidelines
  • Plan de 3 pasos
  • Nuacutemero de diapositiva 21
  • Nuacutemero de diapositiva 22
  • Nuacutemero de diapositiva 23
  • Nuacutemero de diapositiva 24
  • Nuacutemero de diapositiva 25
  • Eur Respir J 2012 Jun39(6)1458-1467 Epub 2012 Jan 20The European Respiratory Society spirometry tent a unique form of screening for airway obstruction
  • Eur Respir J 2012 Jun39(6)1458-1467 Epub 2012 Jan 20The European Respiratory Society spirometry tent a unique form of screening for airway obstruction
  • Nuacutemero de diapositiva 28
  • Nuacutemero de diapositiva 29
  • 13World COPD Day Activities Are they useful to detect lack of medical care and undertreatment in COPD patients13Immunology and Obstructive Lung Diseases Scientific Section from Argentine Respiratory Medicine Association
  • FarmaEPOC
  • Nuacutemero de diapositiva 32
  • Dejar de fumar agrega antildeos de vida
  • Nuacutemero de diapositiva 34
  • Nuacutemero de diapositiva 35
  • Nuacutemero de diapositiva 36
  • CONCLUSIONES
  • Nuacutemero de diapositiva 38

FarmaEPOC

100 farmacias de la provincia de Barcelona realizaraacuten escalonadamente espirometriacuteas ambulatorias a personas con factores de riesgo hasta alcanzar una muestra de 3600 usuarios Las espirometriacuteas seraacuten evaluadas con una aplicacioacuten telemaacutetica que permite no soacutelo garantizar la calidad de las espirometriacuteas realizadas sino mantener una comunicacioacuten on-line entre la farmacia y los laboratorios de funcioacuten pulmonar del Hospital Cliacutenic y el Hospital de Sant Pau FarmaEPOC 2 tiene como objetivo confirmar los datos del estudio piloto FarmaEPOC 1 que concluye la viabilidad de la prueba de la espirometriacutea en la oficina de farmacia De este modo FarmaEPOC 2 da un paso maacutes y surge de la necesidad de conocer tanto las caracteriacutesticas epidemioloacutegicas de los usuarios con alteracioacuten del flujo aeacutereo cribados en farmacias Abandono del tabaco principal estrategia de intervencioacuten precoz

Dejar de fumar agrega antildeos de vida

Aba

ndon

o a

los

45-5

4 antilde

os

Fumadores No fumadores Abandono a los 45-54 antildeos

n=34439 meacutedicos britaacutenicos

Antildeos

de sobrevida

desde edad promedio de 50 antildeos

Abandono en promedio a los 50 antildeos

bull Disminuye la mortalidad (A) bull Disminuye declinacioacuten funcional bull La educacioacuten es central (A)

Doll et al BMJ 2004 328 1519-1527

Seccioacuten de Inmunologiacutea y Enfermedades Obstructivas

2011

External validation to COPD deteccion questionnaire

Bergna M Garcia G Grabre P Alchapar R Larrateguy L Altieri H

Figueroa Casas JC Zabert G Nannini L Pascanky D Fucile S

CuestionariO de Deteccioacuten de EPOC CODE

EDAD gt58 ANtildeOS

gt20 PAQUETESANtildeOS TOS CRONICA

FLEMA CROacuteNICA DISNEA ESFUERZO SEXO MASCULINO

BMIlt22

CON SOLO 3 Sensibilidad de 95 y un VPN del 96

CONCLUSIONES bull Para mejorar los resultados globales de la Epoc

debemos detectarla mas tempranamente

bull Actividades en la comunidad cuestionarios espirometria abreviada son herramientas que colaboran con estos objetivos

bull Detectando y confirmando la Epoc por espirometria nuestros pacientes tendran mas oportunidades

Recomendaciones para el Diagnoacutestico y Tratamiento de la Enfermedad Pulmonar Obstructiva Croacutenica EPOC

Muchas Graciashellip

  • ESTRATEGIAS DE LA DETECCION TEMPRANA DE EPOC
  • Como mejorar nuestro manejo y enfoque sobre EPOC
  • Nuacutemero de diapositiva 3
  • Nuacutemero de diapositiva 4
  • Nuacutemero de diapositiva 5
  • Nuacutemero de diapositiva 6
  • Diferencias en el financiamiento del NIH para enfermedades especiacuteficas en USA
  • Espirometriacutea herramienta clave
  • Espiroacutemetro - Tensioacutemetro
  • Nuacutemero de diapositiva 10
  • Nuacutemero de diapositiva 11
  • COPD - PS
  • COPD ndash Population Screener
  • Nuacutemero de diapositiva 14
  • Nuacutemero de diapositiva 15
  • Nuacutemero de diapositiva 16
  • Nuacutemero de diapositiva 17
  • Nuacutemero de diapositiva 18
  • IPAG International Primary Care Airways Guidelines
  • Plan de 3 pasos
  • Nuacutemero de diapositiva 21
  • Nuacutemero de diapositiva 22
  • Nuacutemero de diapositiva 23
  • Nuacutemero de diapositiva 24
  • Nuacutemero de diapositiva 25
  • Eur Respir J 2012 Jun39(6)1458-1467 Epub 2012 Jan 20The European Respiratory Society spirometry tent a unique form of screening for airway obstruction
  • Eur Respir J 2012 Jun39(6)1458-1467 Epub 2012 Jan 20The European Respiratory Society spirometry tent a unique form of screening for airway obstruction
  • Nuacutemero de diapositiva 28
  • Nuacutemero de diapositiva 29
  • 13World COPD Day Activities Are they useful to detect lack of medical care and undertreatment in COPD patients13Immunology and Obstructive Lung Diseases Scientific Section from Argentine Respiratory Medicine Association
  • FarmaEPOC
  • Nuacutemero de diapositiva 32
  • Dejar de fumar agrega antildeos de vida
  • Nuacutemero de diapositiva 34
  • Nuacutemero de diapositiva 35
  • Nuacutemero de diapositiva 36
  • CONCLUSIONES
  • Nuacutemero de diapositiva 38

Dejar de fumar agrega antildeos de vida

Aba

ndon

o a

los

45-5

4 antilde

os

Fumadores No fumadores Abandono a los 45-54 antildeos

n=34439 meacutedicos britaacutenicos

Antildeos

de sobrevida

desde edad promedio de 50 antildeos

Abandono en promedio a los 50 antildeos

bull Disminuye la mortalidad (A) bull Disminuye declinacioacuten funcional bull La educacioacuten es central (A)

Doll et al BMJ 2004 328 1519-1527

Seccioacuten de Inmunologiacutea y Enfermedades Obstructivas

2011

External validation to COPD deteccion questionnaire

Bergna M Garcia G Grabre P Alchapar R Larrateguy L Altieri H

Figueroa Casas JC Zabert G Nannini L Pascanky D Fucile S

CuestionariO de Deteccioacuten de EPOC CODE

EDAD gt58 ANtildeOS

gt20 PAQUETESANtildeOS TOS CRONICA

FLEMA CROacuteNICA DISNEA ESFUERZO SEXO MASCULINO

BMIlt22

CON SOLO 3 Sensibilidad de 95 y un VPN del 96

CONCLUSIONES bull Para mejorar los resultados globales de la Epoc

debemos detectarla mas tempranamente

bull Actividades en la comunidad cuestionarios espirometria abreviada son herramientas que colaboran con estos objetivos

bull Detectando y confirmando la Epoc por espirometria nuestros pacientes tendran mas oportunidades

Recomendaciones para el Diagnoacutestico y Tratamiento de la Enfermedad Pulmonar Obstructiva Croacutenica EPOC

Muchas Graciashellip

  • ESTRATEGIAS DE LA DETECCION TEMPRANA DE EPOC
  • Como mejorar nuestro manejo y enfoque sobre EPOC
  • Nuacutemero de diapositiva 3
  • Nuacutemero de diapositiva 4
  • Nuacutemero de diapositiva 5
  • Nuacutemero de diapositiva 6
  • Diferencias en el financiamiento del NIH para enfermedades especiacuteficas en USA
  • Espirometriacutea herramienta clave
  • Espiroacutemetro - Tensioacutemetro
  • Nuacutemero de diapositiva 10
  • Nuacutemero de diapositiva 11
  • COPD - PS
  • COPD ndash Population Screener
  • Nuacutemero de diapositiva 14
  • Nuacutemero de diapositiva 15
  • Nuacutemero de diapositiva 16
  • Nuacutemero de diapositiva 17
  • Nuacutemero de diapositiva 18
  • IPAG International Primary Care Airways Guidelines
  • Plan de 3 pasos
  • Nuacutemero de diapositiva 21
  • Nuacutemero de diapositiva 22
  • Nuacutemero de diapositiva 23
  • Nuacutemero de diapositiva 24
  • Nuacutemero de diapositiva 25
  • Eur Respir J 2012 Jun39(6)1458-1467 Epub 2012 Jan 20The European Respiratory Society spirometry tent a unique form of screening for airway obstruction
  • Eur Respir J 2012 Jun39(6)1458-1467 Epub 2012 Jan 20The European Respiratory Society spirometry tent a unique form of screening for airway obstruction
  • Nuacutemero de diapositiva 28
  • Nuacutemero de diapositiva 29
  • 13World COPD Day Activities Are they useful to detect lack of medical care and undertreatment in COPD patients13Immunology and Obstructive Lung Diseases Scientific Section from Argentine Respiratory Medicine Association
  • FarmaEPOC
  • Nuacutemero de diapositiva 32
  • Dejar de fumar agrega antildeos de vida
  • Nuacutemero de diapositiva 34
  • Nuacutemero de diapositiva 35
  • Nuacutemero de diapositiva 36
  • CONCLUSIONES
  • Nuacutemero de diapositiva 38

Seccioacuten de Inmunologiacutea y Enfermedades Obstructivas

2011

External validation to COPD deteccion questionnaire

Bergna M Garcia G Grabre P Alchapar R Larrateguy L Altieri H

Figueroa Casas JC Zabert G Nannini L Pascanky D Fucile S

CuestionariO de Deteccioacuten de EPOC CODE

EDAD gt58 ANtildeOS

gt20 PAQUETESANtildeOS TOS CRONICA

FLEMA CROacuteNICA DISNEA ESFUERZO SEXO MASCULINO

BMIlt22

CON SOLO 3 Sensibilidad de 95 y un VPN del 96

CONCLUSIONES bull Para mejorar los resultados globales de la Epoc

debemos detectarla mas tempranamente

bull Actividades en la comunidad cuestionarios espirometria abreviada son herramientas que colaboran con estos objetivos

bull Detectando y confirmando la Epoc por espirometria nuestros pacientes tendran mas oportunidades

Recomendaciones para el Diagnoacutestico y Tratamiento de la Enfermedad Pulmonar Obstructiva Croacutenica EPOC

Muchas Graciashellip

  • ESTRATEGIAS DE LA DETECCION TEMPRANA DE EPOC
  • Como mejorar nuestro manejo y enfoque sobre EPOC
  • Nuacutemero de diapositiva 3
  • Nuacutemero de diapositiva 4
  • Nuacutemero de diapositiva 5
  • Nuacutemero de diapositiva 6
  • Diferencias en el financiamiento del NIH para enfermedades especiacuteficas en USA
  • Espirometriacutea herramienta clave
  • Espiroacutemetro - Tensioacutemetro
  • Nuacutemero de diapositiva 10
  • Nuacutemero de diapositiva 11
  • COPD - PS
  • COPD ndash Population Screener
  • Nuacutemero de diapositiva 14
  • Nuacutemero de diapositiva 15
  • Nuacutemero de diapositiva 16
  • Nuacutemero de diapositiva 17
  • Nuacutemero de diapositiva 18
  • IPAG International Primary Care Airways Guidelines
  • Plan de 3 pasos
  • Nuacutemero de diapositiva 21
  • Nuacutemero de diapositiva 22
  • Nuacutemero de diapositiva 23
  • Nuacutemero de diapositiva 24
  • Nuacutemero de diapositiva 25
  • Eur Respir J 2012 Jun39(6)1458-1467 Epub 2012 Jan 20The European Respiratory Society spirometry tent a unique form of screening for airway obstruction
  • Eur Respir J 2012 Jun39(6)1458-1467 Epub 2012 Jan 20The European Respiratory Society spirometry tent a unique form of screening for airway obstruction
  • Nuacutemero de diapositiva 28
  • Nuacutemero de diapositiva 29
  • 13World COPD Day Activities Are they useful to detect lack of medical care and undertreatment in COPD patients13Immunology and Obstructive Lung Diseases Scientific Section from Argentine Respiratory Medicine Association
  • FarmaEPOC
  • Nuacutemero de diapositiva 32
  • Dejar de fumar agrega antildeos de vida
  • Nuacutemero de diapositiva 34
  • Nuacutemero de diapositiva 35
  • Nuacutemero de diapositiva 36
  • CONCLUSIONES
  • Nuacutemero de diapositiva 38

External validation to COPD deteccion questionnaire

Bergna M Garcia G Grabre P Alchapar R Larrateguy L Altieri H

Figueroa Casas JC Zabert G Nannini L Pascanky D Fucile S

CuestionariO de Deteccioacuten de EPOC CODE

EDAD gt58 ANtildeOS

gt20 PAQUETESANtildeOS TOS CRONICA

FLEMA CROacuteNICA DISNEA ESFUERZO SEXO MASCULINO

BMIlt22

CON SOLO 3 Sensibilidad de 95 y un VPN del 96

CONCLUSIONES bull Para mejorar los resultados globales de la Epoc

debemos detectarla mas tempranamente

bull Actividades en la comunidad cuestionarios espirometria abreviada son herramientas que colaboran con estos objetivos

bull Detectando y confirmando la Epoc por espirometria nuestros pacientes tendran mas oportunidades

Recomendaciones para el Diagnoacutestico y Tratamiento de la Enfermedad Pulmonar Obstructiva Croacutenica EPOC

Muchas Graciashellip

  • ESTRATEGIAS DE LA DETECCION TEMPRANA DE EPOC
  • Como mejorar nuestro manejo y enfoque sobre EPOC
  • Nuacutemero de diapositiva 3
  • Nuacutemero de diapositiva 4
  • Nuacutemero de diapositiva 5
  • Nuacutemero de diapositiva 6
  • Diferencias en el financiamiento del NIH para enfermedades especiacuteficas en USA
  • Espirometriacutea herramienta clave
  • Espiroacutemetro - Tensioacutemetro
  • Nuacutemero de diapositiva 10
  • Nuacutemero de diapositiva 11
  • COPD - PS
  • COPD ndash Population Screener
  • Nuacutemero de diapositiva 14
  • Nuacutemero de diapositiva 15
  • Nuacutemero de diapositiva 16
  • Nuacutemero de diapositiva 17
  • Nuacutemero de diapositiva 18
  • IPAG International Primary Care Airways Guidelines
  • Plan de 3 pasos
  • Nuacutemero de diapositiva 21
  • Nuacutemero de diapositiva 22
  • Nuacutemero de diapositiva 23
  • Nuacutemero de diapositiva 24
  • Nuacutemero de diapositiva 25
  • Eur Respir J 2012 Jun39(6)1458-1467 Epub 2012 Jan 20The European Respiratory Society spirometry tent a unique form of screening for airway obstruction
  • Eur Respir J 2012 Jun39(6)1458-1467 Epub 2012 Jan 20The European Respiratory Society spirometry tent a unique form of screening for airway obstruction
  • Nuacutemero de diapositiva 28
  • Nuacutemero de diapositiva 29
  • 13World COPD Day Activities Are they useful to detect lack of medical care and undertreatment in COPD patients13Immunology and Obstructive Lung Diseases Scientific Section from Argentine Respiratory Medicine Association
  • FarmaEPOC
  • Nuacutemero de diapositiva 32
  • Dejar de fumar agrega antildeos de vida
  • Nuacutemero de diapositiva 34
  • Nuacutemero de diapositiva 35
  • Nuacutemero de diapositiva 36
  • CONCLUSIONES
  • Nuacutemero de diapositiva 38

CuestionariO de Deteccioacuten de EPOC CODE

EDAD gt58 ANtildeOS

gt20 PAQUETESANtildeOS TOS CRONICA

FLEMA CROacuteNICA DISNEA ESFUERZO SEXO MASCULINO

BMIlt22

CON SOLO 3 Sensibilidad de 95 y un VPN del 96

CONCLUSIONES bull Para mejorar los resultados globales de la Epoc

debemos detectarla mas tempranamente

bull Actividades en la comunidad cuestionarios espirometria abreviada son herramientas que colaboran con estos objetivos

bull Detectando y confirmando la Epoc por espirometria nuestros pacientes tendran mas oportunidades

Recomendaciones para el Diagnoacutestico y Tratamiento de la Enfermedad Pulmonar Obstructiva Croacutenica EPOC

Muchas Graciashellip

  • ESTRATEGIAS DE LA DETECCION TEMPRANA DE EPOC
  • Como mejorar nuestro manejo y enfoque sobre EPOC
  • Nuacutemero de diapositiva 3
  • Nuacutemero de diapositiva 4
  • Nuacutemero de diapositiva 5
  • Nuacutemero de diapositiva 6
  • Diferencias en el financiamiento del NIH para enfermedades especiacuteficas en USA
  • Espirometriacutea herramienta clave
  • Espiroacutemetro - Tensioacutemetro
  • Nuacutemero de diapositiva 10
  • Nuacutemero de diapositiva 11
  • COPD - PS
  • COPD ndash Population Screener
  • Nuacutemero de diapositiva 14
  • Nuacutemero de diapositiva 15
  • Nuacutemero de diapositiva 16
  • Nuacutemero de diapositiva 17
  • Nuacutemero de diapositiva 18
  • IPAG International Primary Care Airways Guidelines
  • Plan de 3 pasos
  • Nuacutemero de diapositiva 21
  • Nuacutemero de diapositiva 22
  • Nuacutemero de diapositiva 23
  • Nuacutemero de diapositiva 24
  • Nuacutemero de diapositiva 25
  • Eur Respir J 2012 Jun39(6)1458-1467 Epub 2012 Jan 20The European Respiratory Society spirometry tent a unique form of screening for airway obstruction
  • Eur Respir J 2012 Jun39(6)1458-1467 Epub 2012 Jan 20The European Respiratory Society spirometry tent a unique form of screening for airway obstruction
  • Nuacutemero de diapositiva 28
  • Nuacutemero de diapositiva 29
  • 13World COPD Day Activities Are they useful to detect lack of medical care and undertreatment in COPD patients13Immunology and Obstructive Lung Diseases Scientific Section from Argentine Respiratory Medicine Association
  • FarmaEPOC
  • Nuacutemero de diapositiva 32
  • Dejar de fumar agrega antildeos de vida
  • Nuacutemero de diapositiva 34
  • Nuacutemero de diapositiva 35
  • Nuacutemero de diapositiva 36
  • CONCLUSIONES
  • Nuacutemero de diapositiva 38

CONCLUSIONES bull Para mejorar los resultados globales de la Epoc

debemos detectarla mas tempranamente

bull Actividades en la comunidad cuestionarios espirometria abreviada son herramientas que colaboran con estos objetivos

bull Detectando y confirmando la Epoc por espirometria nuestros pacientes tendran mas oportunidades

Recomendaciones para el Diagnoacutestico y Tratamiento de la Enfermedad Pulmonar Obstructiva Croacutenica EPOC

Muchas Graciashellip

  • ESTRATEGIAS DE LA DETECCION TEMPRANA DE EPOC
  • Como mejorar nuestro manejo y enfoque sobre EPOC
  • Nuacutemero de diapositiva 3
  • Nuacutemero de diapositiva 4
  • Nuacutemero de diapositiva 5
  • Nuacutemero de diapositiva 6
  • Diferencias en el financiamiento del NIH para enfermedades especiacuteficas en USA
  • Espirometriacutea herramienta clave
  • Espiroacutemetro - Tensioacutemetro
  • Nuacutemero de diapositiva 10
  • Nuacutemero de diapositiva 11
  • COPD - PS
  • COPD ndash Population Screener
  • Nuacutemero de diapositiva 14
  • Nuacutemero de diapositiva 15
  • Nuacutemero de diapositiva 16
  • Nuacutemero de diapositiva 17
  • Nuacutemero de diapositiva 18
  • IPAG International Primary Care Airways Guidelines
  • Plan de 3 pasos
  • Nuacutemero de diapositiva 21
  • Nuacutemero de diapositiva 22
  • Nuacutemero de diapositiva 23
  • Nuacutemero de diapositiva 24
  • Nuacutemero de diapositiva 25
  • Eur Respir J 2012 Jun39(6)1458-1467 Epub 2012 Jan 20The European Respiratory Society spirometry tent a unique form of screening for airway obstruction
  • Eur Respir J 2012 Jun39(6)1458-1467 Epub 2012 Jan 20The European Respiratory Society spirometry tent a unique form of screening for airway obstruction
  • Nuacutemero de diapositiva 28
  • Nuacutemero de diapositiva 29
  • 13World COPD Day Activities Are they useful to detect lack of medical care and undertreatment in COPD patients13Immunology and Obstructive Lung Diseases Scientific Section from Argentine Respiratory Medicine Association
  • FarmaEPOC
  • Nuacutemero de diapositiva 32
  • Dejar de fumar agrega antildeos de vida
  • Nuacutemero de diapositiva 34
  • Nuacutemero de diapositiva 35
  • Nuacutemero de diapositiva 36
  • CONCLUSIONES
  • Nuacutemero de diapositiva 38

Recomendaciones para el Diagnoacutestico y Tratamiento de la Enfermedad Pulmonar Obstructiva Croacutenica EPOC

Muchas Graciashellip

  • ESTRATEGIAS DE LA DETECCION TEMPRANA DE EPOC
  • Como mejorar nuestro manejo y enfoque sobre EPOC
  • Nuacutemero de diapositiva 3
  • Nuacutemero de diapositiva 4
  • Nuacutemero de diapositiva 5
  • Nuacutemero de diapositiva 6
  • Diferencias en el financiamiento del NIH para enfermedades especiacuteficas en USA
  • Espirometriacutea herramienta clave
  • Espiroacutemetro - Tensioacutemetro
  • Nuacutemero de diapositiva 10
  • Nuacutemero de diapositiva 11
  • COPD - PS
  • COPD ndash Population Screener
  • Nuacutemero de diapositiva 14
  • Nuacutemero de diapositiva 15
  • Nuacutemero de diapositiva 16
  • Nuacutemero de diapositiva 17
  • Nuacutemero de diapositiva 18
  • IPAG International Primary Care Airways Guidelines
  • Plan de 3 pasos
  • Nuacutemero de diapositiva 21
  • Nuacutemero de diapositiva 22
  • Nuacutemero de diapositiva 23
  • Nuacutemero de diapositiva 24
  • Nuacutemero de diapositiva 25
  • Eur Respir J 2012 Jun39(6)1458-1467 Epub 2012 Jan 20The European Respiratory Society spirometry tent a unique form of screening for airway obstruction
  • Eur Respir J 2012 Jun39(6)1458-1467 Epub 2012 Jan 20The European Respiratory Society spirometry tent a unique form of screening for airway obstruction
  • Nuacutemero de diapositiva 28
  • Nuacutemero de diapositiva 29
  • 13World COPD Day Activities Are they useful to detect lack of medical care and undertreatment in COPD patients13Immunology and Obstructive Lung Diseases Scientific Section from Argentine Respiratory Medicine Association
  • FarmaEPOC
  • Nuacutemero de diapositiva 32
  • Dejar de fumar agrega antildeos de vida
  • Nuacutemero de diapositiva 34
  • Nuacutemero de diapositiva 35
  • Nuacutemero de diapositiva 36
  • CONCLUSIONES
  • Nuacutemero de diapositiva 38